Document:

Exhibit 4.12

Share Purchase Agreement

Santémedia Holding S.à r.l.

And

United Business Media Group Limited

for the sale and purchase of the Shares

16 June 2004

1

CONTENTS

	
  
CLAUSE
  	
   
 	
  
PAGE
  
	
  

  	
  
 
  	
  

  
	
  
1.
  	
  
INTERPRETATION
  	
  
4
  
	
  2.
  	
  
SALE AND   PURCHASE
  	
  
10
  
	
  
3.
  	
  
PURCHASE   PRICE
  	
  
10
  
	
  
4.
  	
  
CONDITIONS   PRECEDENT
  	
  
13
  
	
  
5.
  	
  
ACTIONS BY   THE PARTIES PRIOR TO THE COMPLETION DATE
  	
  
14
  
	
  
6.
  	
  
COMPLETION
  	
  
16
  
	
  
7.
  	
  
COMPLETION   STATEMENT
  	
  
17
  
	
  
8.
  	
  
SALE OF THE   ATMEDICA INDIAN SHARES
  	
  
20
  
	
  9.
  	
  
POST   COMPLETION UNDERTAKINGS OF THE PARTIES
  	
  
20
  
	
  
10.
  	
  
COVENANT UP   TO COMPLETION
  	
  
23
  
	
  
11.
  	
  
WARRANTIES   OF THE SELLER
  	
  
25
  
	
  
12.
  	
  
WARRANTIES   OF THE BUYER
  	
  
25
  
	
  
13.
  	
  
ACCESS TO   INFORMATION
  	
  
26
  
	
  
14.
  	
  
NON-SOLICITATION
  	
  
27
  
	
  
15.
  	
  
NON   COMPETITION
  	
  
27
  
	
  16.
  	
  
ANNOUNCEMENTS   - CONFIDENTIALITY - CONFIDENTIAL INFORMATION
  	
  
28
  
	
  
17.
  	
  
COSTS
  	
  
29
  
	
  
18.
  	
  
ASSIGNMENT
  	
  
29
  
	
  
19.
  	
  
FURTHER   ASSURANCES
  	
  
30
  
	
  
20.
  	
  
WAIVER
  	
  
30
  
	
  
21.
  	
  
INVALIDITY
  	
  
30
  
	
  
22.
  	
  
NOTICES
  	
  
30
  
	
  23.
  	
  
SUBSTITUTION   OF THE BUYER
  	
  
31
  
	
  
24.
  	
  
SCHEDULES
  	
  
32
  
	
  
25.
  	
  
AMENDMENTS
  	
  
32
  
	
  
26.
  	
  
ENTIRE   AGREEMENT
  	
  
32
  
	
  
27.
  	
  
GOVERNING   LAW - JURISDICTION
  	
  
32
  
	
  
LIST OF   SCHEDULES
  	
  
33
  
	
  
SCHEDULE A
  	
  
34
  
	
  
SCHEDULE B
  	
  
36
  
	
  SCHEDULE C
  	
  
38
  
	
  
SCHEDULE D
  	
  
41
  
	
  
SCHEDULE E
  	
  
42
  
	
  
SCHEDULE F
  	
  
43
  
	
  
SCHEDULE G
  	
  
44
  
	
  
SCHEDULE H
  	
  
50
  
	
  
SCHEDULE I
  	
  
51
  
	
  
SCHEDULE J
  	
  
52
  
	
  
SCHEDULE J.1
  	
  
53
  
	
  
SCHEDULE J.2
  	
  
54
  
	
  SCHEDULE J.3
  	
  
55
  
	
  
SCHEDULE J.4
  	
  
56
  
	
  
SCHEDULE J.5
  	
  
57
  
	
  
SCHEDULE K
  	
  
58
  
	
  
SCHEDULE L
  	
  
59
  
	
  
SCHEDULE M
  	
  
61
  
	
  
SCHEDULE N
  	
  
64
  
	
  
SCHEDULE O
  	
  
65
  

	
  
SCHEDULE P
  	
  
66
  
	
  SCHEDULE Q
  	
  
67
  
	
  
SCHEDULE R
  	
  
68
  
	
  
SCHEDULE S
  	
  
69
  
	
  
SCHEDULE T
  	
  
75
  
	
  
SCHEDULE U
  	
  
80
  
	
  
SCHEDULE V
  	
  
81
  

SHARE PURCHASE AGREEMENT

BETWEEN:

	
  
(1)
  	
  
SANTEMEDIA HOLDING S.à r.l., a société à responsabilité limitée organised   under the laws of the Grand Duchy of Luxembourg, with a share capital of €   1,560,725, having its registered office at 5, Parc d’Activité Syrdall, L-5365   Münsbach, Luxembourg, represented by Mr François Mirallié, duly empowered   (the “Seller”),
  

ON THE FIRST HAND.

	
  
AND:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
(2)
  	
  
UNITED BUSINESS MEDIA GROUP LIMITED (n°01693134), a   private limited company, with an issued share capital of £ 379,469, having   its registered office at Ludgate House, 245 Blackfriars Road, London SE1 9UY,   United Kingdom, represented by Mr Nigel Wilson, duly empowered, (the “Buyer”),
  

ON THE SECOND HAND.

	
  
WHEREAS:
  
	
  
 
  	
  
 
  
	
  
(A)
  	
  
The Seller   is and shall be, the direct or indirect owner, or as the case may be, the   direct beneficial owner, of the Shares and the Atmedica Indian Shares (as   such terms are defined below).
  
	
   
  	
  
 
  
	
  
(B)
  	
  
The Seller   shall, on the Completion Date (as defined below), own indirectly   shareholdings, or as the case may be, beneficial ownership of the shares, in   the Subsidiaries listed under schedule C.
  
	
  
 
  	
  
 
  
	
  
(C)
  	
  
The Seller   has agreed to sell, or to procure, the sale of the Shares and, as the case   may be, of the Atmedica Indian Shares, to the Buyer at a price and under the   terms and conditions defined in this share purchase agreement and the Buyer   agrees to purchase all of the Shares and, as the case may be, the Atmedica   Indian Shares, under the terms and conditions defined below.
  

THE PARTIES AGREE AS FOLLOWS:

	
  
1.
  	
  
INTERPRETATION
  
	
  
 
  	
  
 
  
	
  
1.1
  	
  
In this   Agreement (as such term is defined below) the following words and expressions   and abbreviations set out below and starting with a capital letter shall have   the following meanings, unless the context otherwise requires:
  
	
   
  	
  
 
  
	
  
 
  	
  
“Accounts” means the special purpose audited   and certified combined accounts (including the special purpose combined   balance sheet and profit and loss statement and notes) of the Group as at the   Accounting Date drawn up in accordance with the Accounting Policies, a copy   of which is attached to the Disclosure Letter;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Accounting Date” means 31 December 2003;
  

4

	
  
 
  	
  
”Accounting Policies” means the accounting   policies and procedures set out in schedule D or, to the extent not   set out in schedule D, French GAAP;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Additional Disclosures” means any event,   fact, matter or circumstance arising or occurring between the date of this   Agreement and the Completion Date and relating to any Group Company   (including, Atmedica India Pvt Ltd), and fairly disclosed to the Buyer and   its advisers by the Seller or the Seller’s Group or the Group (including,   Atmedica India Pvt Ltd) or any of their advisers on account of any Warranty   of the Seller;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Agreed Rate” means an interest calculated   on the basis of Euribor 3 months plus 0.5 per cent.;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Agreement” means this share purchase   agreement and each of its schedules;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Anti-Trust Clearance” means (i) a decision   from the relevant applicable anti-trust authority in Portugal and Spain,   which, in accordance with the relevant applicable anti-trust laws, authorises   or does not prevent, the concentration resulting from the Contemplated   Transaction or, (ii) the expiry of the applicable waiting period which is   deemed to be an official waiver from the relevant applicable anti-trust   authority in Portugal or in Spain, under the applicable local anti-trust   laws, as the case may be;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Assets” shall bear the meaning given to   such term in clause 8 of schedule S;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Atmedica Indian Agreement” means the   shareholders’ agreement dated 21 December 2001 (such agreement being a   Disclosed Information) entered into between K. Venkatraman, P.V.V. Krishnan,   Lakshmi Krishnan and, pursuant to an accession agreement, the Seller, in   respect of Atmedica India Pvt Ltd, and any amendments thereof;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Atmedica Indian Consent” means the prior   written consent of Mr. K. Venkatraman to the transfer of the Atmedica Indian   Shares by the Seller to the Buyer and to be granted under the Atmedica Indian   Agreement;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Atmedica India Pvt Ltd” means Atmedica   (India) Private Ltd, a company organised under the laws of India, having its   registered office at 640, 10-‘A’ Cross, West of Choard Road, Bangalore-560   086, India;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Atmedica Indian Shares” means one hundred   twenty (120) shares, representing together sixty per cent. (60%) of the share   capital of Atmedica India Pvt Ltd, held by the Seller;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Authorized Exception” shall bear the   meaning given to such term in clause 9.11;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Business” means the activities carried out   by the Group (and Atmedica India Pvt Ltd, as the case may be), as at the date   of this Agreement, being: (i) compiling, distributing and marketing, by all   methods and means (in particular directories, CD Roms, internet or other   electronic media) drug databases (including in particular, the active   substances and the form of dosage), such databases intended for sale or   distribution free of charge to professionals in the health industry (doctors,   pharmacists, hospitals, physicians...) and to insurance companies and (ii)   editing, publishing, selling or distributing the “Healthcare professionals trade   magazine” defined as being professional journals sold or distributed free of   charge, primarily for the benefit of doctors, dentists, vets and pharmacists;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Business Day” means a day (excluding   Saturdays, Sundays and public holidays in France and Luxembourg) on which   banks generally are open in Luxembourg and France for the transaction of   normal banking business;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Buyer’s Account” means the bank account in   the name of the Buyer details of which will be provided in writing by the   Buyer to the Seller by no later than two (2) Business Days prior to the   Seller (or any member of the Seller’s Group) being required to make any   payment to that account;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Buyer’s Group” means the Buyer, its holding   companies and United Business Media Plc and the subsidiaries, undertakings   and associated companies from time to time of such holding companies and of   the Buyer and of United Business Media Plc, (including, as from Completion   Date, the Group), all of them and each of them as the context admits;
  

5

	
  
 
  	
  
”Cash” shall bear the meaning given to such   term in clause 2 of schedule V;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
“Claim” means, subject to the provisions of schedule   T (unless otherwise provided under clause 5.1(c)), a claim made by the   Buyer against the Seller under clause 11, or as a result of a breach of a   covenant by the Seller set out in clause 10 or under clause 5.1(c), in   respect of a loss (préjudice), and including as a result of   proceedings, claims or demands (but excluding any consequential ones) made by   a Third Party;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Company” means any of the companies listed   under schedule B, and, subject to the Indian Completion taking place,   Atmedica India Pvt Ltd, and “Companies” means   all of the companies listed under schedule B together with, subject to   the Indian Completion taking place, Atmedica India Pvt Ltd;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Completion” means the completion of the   transfer of ownership of the Shares by the Seller to the Buyer in accordance   with clause 6;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
“Completion Accounts” means the combined   balance sheet and profit and loss statement of the Companies (including,   notwithstanding the date of the Indian Completion, Atmedica Indian Pvt Ltd)   and the Subsidiaries as at the Completion Date to be drawn up in accordance   with clause 7 and in compliance with the Accounting Policies;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Completion Date” means the date of transfer   of ownership of the Shares by the Seller to the Buyer in accordance with   clause 6.1;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Completion Payment” shall mean an amount   paid at the Completion Date by the Buyer to the Seller, on account of the   Total Price, in accordance with the provisions of clause 6.3, and calculated   as follows:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
Completion   Payment = Price of Shares Pre-Adjustment - (Estimated Intra-Group Payables +   Estimated Debt) + (Estimated Intra-Group Receivables + Estimated Cash);
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Completion Statement” means a document in   the format set out in schedule E to be prepared in accordance with   clause 7 and on the basis of the Completion Accounts;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Conditions Precedent” shall bear the   meaning given to such term in clause 4.1;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Contemplated Transaction” means the   transactions contemplated under this Agreement;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Debt” shall bear the meaning given to such   term in clause 1 of schedule V:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Default Rate” means an interest calculated   on the basis of Euribor 3 months plus 2 per cent.;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Disclosed Information” means the collection   of documents, material and information relating to the Group (including,   Atmedica India Pvt Ltd) disclosed or made available for inspection to the   Buyer and its advisers by the Seller or the Seller’s Group or the Group   (including, Atmedica India Pvt Ltd) or any of their advisers and attached to   the Disclosure Letter;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Disclosure Letter” means the letter   (together with its exhibits) dated the date of this Agreement from the Seller   to the Buyer in connection with the Warranties of the Seller;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
“Doyma” means Ediciones Doyma SL, a limited   liability company organised under the laws of Spain, with a share capital of   € 28,360,604.34, having its registered office at Calle Travessera de Gracia,   17-21 Barcelona, Spain;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
“Encumbrance” means all charges, mortgage,   lien, restrictions, assignment, guarantees, privileges, pledges, options,   preferential rights, hypothecation, security interest, title retention or any   other agreement or arrangement the effect of which is the creation of   security, or any other interest, equity or other right of any person   (including right to acquire, right of first refusal or right of pre-emption   of any nature whatsoever), or any agreement or arrangement to create any of   the same;
  

6

	
  
 
  	
  
”Estimated Cash” means the amount of the   Cash estimated by the Seller and provided to the Buyer in accordance with   clause 5.1;
  
	
  
 
  	
  
 
  
	
   
  	
  
“Estimated Debt” means the amount of the   Debt estimated by the Seller and provided to the Buyer in accordance with   clause 5.1;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Estimated Intra-Group Payables” means the   amount of the Intra-Group Payables estimated by the Seller and provided to   the Buyer in accordance with clause 5.1;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Estimated Intra-Group Receivables” means   the amount of the Intra-Group Receivables estimated by the Seller and   provided to the Buyer in accordance with clause 5.1;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Expert” shall bear the meaning given to   such term in clause 7.6;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“France Shares” means one million three   hundred fifty three thousand (1,353,000) shares, representing together one   hundred per cent (100%) of the share capital of Vidal SA (being a Company),   held by MMHF;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Group” means the Companies and the   Subsidiaries;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Group Company” means any of the Companies   and the Subsidiaries and “Group Companies” shall   be construed accordingly;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Guarantees” shall bear the meaning given to   such term in clause 9.5;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“HCN Tax Liabilities” shall bear the meaning   given to such term in clause 5.1(c)(iii);
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“HCN Transaction” shall bear the meaning   given to such term in clause 5.1(c)(iii);
  
	
   
  	
  
 
  
	
  
 
  	
  
“Indian Completion” shall bear the meaning   given to such term in clause 8.4;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Indian Price” shall bear the meaning given   to such term in clause 8.1;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Insurance Policies” shall bear the meaning   given to such term in clause 11 of schedule S;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Intellectual Property” means any trade   marks, copyrights (including rights in computer software), rights in   databases, domain names and business names and applications to register any   of the aforesaid items;
  
	
  
 
  	
  
 
  
	
   
  	
  
“Intra-Group Agreements” means the   agreements entered into between any Group Company and members of the Seller’s   Group listed under schedule L and to be terminated by no later than   the Completion Date;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Intra-Group Payables” means the aggregate   of the amounts owing from members of the Group to members of the Seller’s   Group (excluding amounts owing in respect of intra-group trading activities   in the ordinary course of business) as at the close of business on the Completion   Date, as set out in the Completion Statement and calculated in accordance   with clause 7 and on the basis of the Accounting Policies; it being specified   that (i) each item taken into account for the determination and calculation   of the Debt and/or the Working Capital shall not be taken into account for   the determination and calculation of the Intra-Group Payables and (ii) for   the purposes of this definition, notwithstanding the date of the Indian   Completion, Atmedica India Pvt Ltd shall be considered as a member of the   Group;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Intra-Group Receivables” means the   aggregate of the amounts owing from members of the Seller’s Group to members   of the Group (excluding amounts owing in respect of intra-group trading   activities in the ordinary course of business) as at the close of business on   the Completion Date, as set out in the Completion Statement and calculated in   accordance with clause 7 and on the basis of the Accounting Policies; it   being specified that (i) each item taken into account for the determination   and calculation of the Cash and/or the Working Capital shall not be taken   into account for the determination and calculation of the Intra-Group   Receivables and (ii) for the purposes of this definition, notwithstanding the   date of the Indian Completion, Atmedica India Pvt Ltd shall be considered as   a member of the Group;
  

7

	
  
 
  	
  
“Key Employees” shall bear the meaning given   to such term in clause 6 of schedule S;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Licence Agreements” means together: (a)   each of the “Krames” licensing   agreements in the agreed form set out in schedule O to be entered into   at the Completion Date by The StayWell Company d/b/a Krames (a member of the   Seller’s Group) with the following Companies or Subsidiaries: (i) MediMedia   Pacific Ltd, (ii) MediMedia Australia Pty Ltd, (iii) Vidal SA, (iv) MediMedia   International SP Zoo, (v) MediMedia Informations KFT, (vi) MediMedia Holding   Germany GmbH, and (vii) MediMedia Netherlands BV; and (b) the agreement to be   entered into between Oxney Information BV (a member of the Seller’s Group)   and Vidal SA whereby Oxney Information BV renews, for a five year (5) period   as from 31 July 2004, under the same terms and conditions than those provided   under the licence agreement dated 20 November 2000, the licence of the trademark   “Tarex”;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Material Contracts” shall bear the meaning   given to such term in clause 5 of schedule S;
  
	
   
  	
  
 
  
	
  
 
  	
  
“MMHF” means MediMedia Holding France SAS, a   société par actions simplifiée organised   under the laws of France, with a share capital of € 34,038,500, having its   registered office at 21-23, rue Camille Desmoulins, 92130   Issy-les-Moulineaux, France;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Party” means individually either the Seller   or the Buyer and “Parties” means   together, the Seller and the Buyer;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Price of Shares Pre-Adjustment” means the   total consideration for all of the Shares, being an amount of two hundred   eighty-two million five hundred thousand euros (€ 282,500,000) (including,   for the avoidance of doubt, the “Indian   Price”);
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Properties” shall bear the meaning given to   such term in clause 7 of schedule S or any part or parts thereof and “Property” shall mean any one of them;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Records” shall bear the meaning given to   such term in clause 9.7;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Reference Working Capital” shall mean:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(i)
  	
  
the amount   of five million seven hundred sixty thousand euros (€ 5,760,000) in the event   that the 2004 edition of the Spanish “Vademecum” directory is published by   MediMedia Medicom SA before the Completion Date and its related revenues are   recognised on or prior to the Completion Date; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(ii)
  	
  
the amount   of one million sixty thousand euros (€ 1,060,000) in the event that the 2004   edition of the Spanish “Vademecum” directory is not published by MediMedia   Medicom SA before the Completion Date and its related revenues are not   recognised on/prior to the Completion Date;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Remuneration” shall bear the meaning given   to such term in clause 6 of schedule S;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Retained Trademarks” means any trade or   service marks, trade or service names, logos, domain names, data bases rights,   copyrights, editorial contents and software rights (including the words or   any word or words confusingly similar thereto) registered by any Group   Company under its own name and/or used by any Group Company and listed under schedule   N;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Santémedia Beneficial Ownership” means the   beneficial ownership or interest in the shares of the Companies held by the   Seller and listed under schedule A (paragraph B);
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Santemédia Shares” means the shares of the   Companies (other than the France Shares and the Spain Shares) held directly   by the Seller and listed under schedule A (paragraph A), including,   but subject to the Indian Completion taking place, the Atmedica Indian   Shares;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Security Documents” means the agreements   listed under schedule M;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Seller’s Account” means the bank account in   the name of the Seller details of which will be provided in writing by the   Seller to the Buyer by no later than two (2) Business Days prior to the Buyer   being required to make payment to that account;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Seller’s Advisor” means Ashurst of 22, rue   de Marignan, 75008 Paris - France;
  

8

	
  
 
  	
  
“Seller’s Group” means the Seller, its   direct shareholder and the subsidiaries, undertakings and associated   companies of the Seller or of its direct shareholder from time to time (but   excluding any Group Company), all of them and each of them as the context   admits;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Seller’s Group Value” means, for the   purposes of clause 9.10 of this Agreement, the value of the Seller’s Group   calculated as follows:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
Seller’s   Group Value = (EBITDA x 10.5) less Net Financial Debt; 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
Where:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
“EBITDA” means profit from ordinary   operations before financial income and expenses, income tax, depreciation and   amortization for the twelve (12) months period following the date of a   Seller’s Transaction; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
“Net Financial Debt” means: the total amount   of senior bank debt, overdraft and negative bank accounts and other debt of   financial nature (including bonds, but excluding any subordinated debt   subscribed by the ultimate shareholders of the Seller) LESS the total amount   of Cash (as defined under schedule V): and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
being   provided that EBITDA and Net Financial Debt of the Seller’s Group will be   calculated on a consolidated basis;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Seller’s Transaction” shall bear the   meaning given to such term in clause 9.10;
  
	
  
 
  	
  
 
  
	
   
  	
  
“Shares” means together the France Shares,   the Spain Shares, the Santémedia Shares and the Santémedia Beneficial   Ownership;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Spain Shares” means ten thousand (10,000)   shares, representing together one hundred per cent. (100%), of the share   capital of MediMedia Medicom SA (being a Company), held by Doyma;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Subsidiary” means a subsidiary of the   Companies, as listed in schedule C, and “Subsidiaries” means all those subsidiaries listed in schedule   C:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Substituted Buyer” shall bear the meaning   given to such term in clause 23;
  
	
  
 
  	
  
 
  
	
   
  	
  
“Tax” means all form of taxation, whether   direct or indirect, including corporate taxes, withholdings, duties, levies,   imposts, précompte, property   tax, business tax (taxe professionnelle), stamp duties, value added taxes,   customs and excise duties, social security contributions and rates imposed by   any local, municipal, governmental, state, federal or other body in the   jurisdiction of the relevant Group Company (including, India, as the case may   be) and any interest, penalty, surcharge or fine in connection therewith and “Taxation” shall be construed   accordingly;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Tax Action List” shall bear the meaning   given to such term in clause 5.1(d);
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Third Party” means any person, whether an   individual or an entity that is not a Party to this Agreement and excluding   any member of the Seller’s Group, of the Group and of the Buyer’s Group;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Total Price” shall bear the meaning given   to such term in clause 3.1;
  
	
   
  	
  
 
  
	
  
 
  	
  
“Transitional Services Agreements” means   together the agreements in the agreed form set out in schedule O to be   entered into at the Completion Date between (i) MediMedia Support EURL (a   member of the Seller’s Group) and Vidal SA and (ii) Doyma and MediMedia   Medicom SA;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Warranties of the Buyer” shall bear the   meaning given to such term in clause 12; 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Warranties of the Seller” means the   statements of the Seller set out in schedule S;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
“Warranties’ Statement”
means the statement (together with the Additional Disclosures) to be
delivered by the Seller to the Buyer on the Completion Date whereby the Seller,
subject to the Agreement, the Disclosed Information, the Disclosure Letter
and the   Additional Disclosures, restates the Warranties as at the Completion Date   (save on account of clause 14 of schedule S);
 

9

	
  
 
  	
  
 
  
	
  
 
  	
  
“Working Capital” shall bear the meaning   given to such term in clause 3 of schedule V.
  
	
  
 
  	
  
 
  
	
  
1.2
  	
  
In this   Agreement, unless otherwise specified, reference to:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
a document   in the “agreed form” is a   reference to that document in the form approved by or on behalf of each   Party;
  
	
   
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
“includes” and “including” shall mean   including without limitation;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
“clause”, “paragraph” or “schedule” is a   reference to a clause or a paragraph of or a schedule to this Agreement;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
“writing” includes any methods of   representing words in a legible form (other than writing on an electronic or   visual display screen), or other writing in non-transitory form; and
  
	
  
 
  	
  
 
  
	
   
  	
  
(e)
  	
  
words   denoting the singular shall include the plural and vice versa and words   denoting any gender shall include all genders.
  
	
  
 
  	
  
 
  
	
  
1.3
  	
  
Any   statement in this Agreement (including its schedules, and in particular schedule   S), qualified by the expression “to the   knowledge of the Seller” or any similar expression shall be deemed   to mean the actual knowledge of the Seller after due and careful enquiry of:   Mr Stephen Warshaw, Mr Fabien Redon, Mr Vincent Bouvier, Mr Jean-Pierre   Dehaspe, Mr Louis Shilders, Mr Uwe Richter, Mrs Mei Chan Wong, Mr Ben Yeo, Mr   Chris Wills, Mrs Kerry McCartney, Mr Javier Sanz, Mr François Mirallié and   Mrs Marie-Michèle. Blouin.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
SALE AND PURCHASE
  
	
  
 
  	
  
 
  
	
  
2.1
  	
  
Upon the   terms and subject to the conditions of the Agreement, the Seller shall sell   the Santémedia Shares to the Buyer and shall procure that MMHF sells the   France Shares to the Buyer and that Doyma sells the Spain Shares to the   Buyer, and the Buyer shall purchase the Shares, with effect at the Completion   Date, free from any Encumbrance together with all accrued benefits and rights   attached thereto.
  
	
   
  	
  
 
  
	
  
2.2
  	
  
The transfer   of the Shares shall occur on the Completion Date upon satisfaction of the   terms and conditions provided for in clause 6 below for the purpose of   transferring the Shares to the Buyer with all rights attached to them.
  
	
  
 
  	
  
 
  
	
  
3.
  	
  
PURCHASE PRICE
  
	
  
 
  	
  
 
  
	
  
3.1
  	
  
The total   price for the sale and purchase of the Shares (the “Total Price”) to be paid by the Buyer to the Seller shall   be equal to:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
Price of   Shares Pre-Adjustment - (Intra-Group Payables + Debt) + (Intra-Group   Receivables + Cash); and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
either:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
plus the   amount by which the Working Capital exceeds the sum of (Reference Working   Capital + € 2,000,000), if the Working Capital is more than two million euros   (€ 2,000,000) greater than the Reference Working Capital; or
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
less the   amount by which the Working Capital is less than the sum of (Reference   Working Capital - € 2,000,000), if the Working Capital is more than two   million euros (€2,000,000) less than the Reference Working Capital.
  

10

	
  
3.2
  	
  
Within five   (5) Business Days of agreement or determination of the Cash, the Debt, the   Intra-Group Payables, the Intra-Group Receivables and the Working Capital, in   accordance with the provisions of clause 7, and subject to clause 3.6:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
the Seller,   if and to the extent that:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
the   Intra-Group Receivables are greater than the Estimated Intra-Group   Receivables; and/or
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
the   Intra-Group Payables are less than the Estimated Intra-Group Payables;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
shall (for   itself and on behalf of the relevant member of the Seller’s Group) pay or, as   the case may be, repay (or procure that the relevant member of the Seller’s   Group pay(s) or, as the case may be, repay(s)) in cash an amount equal to the   aggregate of such differences, by way of telegraphic transfer in immediately   available funds to the Buyer’s Account, together with interest thereon at the   Agreed Rate for the period from the Completion Date to the date of the actual   payment (both dates inclusive), against payment by the Buyer to the Seller,   by way of telegraphic transfer to the Seller’s Account, of an amount equal   thereto (which latter payment shall take effect as an adjustment, by way of   increase, in the Completion Payment); and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(b)
  	
  
the Buyer,   if and to the extent that:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
the   Intra-Group Receivables are less than the Estimated Intra-Group Receivables;   and/or
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
the   Intra-Group Payables are greater than the Estimated Intra-Group Payables,
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
shall (for   itself and on behalf of the relevant member(s) of the Group) pay or, as the   case may be, repay (or procure that the relevant member(s) of the Group   pay(s) or, as the case may be, repay(s)) in cash an amount equal to the   aggregate of such differences, by way of telegraphic transfer in immediately   available funds to the Seller’s Account, together with interest thereon at   the Agreed Rate for the period from the Completion Date to the date of the   actual payment (both dates inclusive), against payment by the Seller to the   Buyer, by way of telegraphic transfer to the Buyer’s Account, of an amount   equal thereto (which latter payment shall take effect as an adjustment, by   way of reduction, in the Completion Payment).
  
	
  
 
  	
  
 
  
	
  
3.3
  	
  
Within five   (5) Business Days of agreement or determination of the Cash, the Debt, the   Intra-Group Payables, the Intra-Group Receivables and the Working Capital, in   accordance with the provisions of clause 7, and subject to clause 3.6:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
the Seller,   if and to the extent that:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
(i)
  	
  
the Debt is   greater than the Estimated Debt; and/or
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
the Cash is   less than the Estimated Cash;
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
shall pay   or, as the case may be, repay in cash an amount equal to the aggregate of   such differences, by way of telegraphic transfer in immediately available   funds to the Buyer’s Account, together with interest thereon at the Agreed   Rate for the period from the Completion Date to the date of the actual   payment (both dates inclusive), which payment shall take effect as an adjustment,   by way of reduction, in the Completion Payment; and
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Buyer,   if and to the extent that:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
the Debt is   less than the Estimated Debt; and/or
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
the Cash is   greater than the Estimated Cash;
  

11

	
  
 
  	
  
 
  	
  
shall pay in   cash an amount equal to the aggregate of such differences, by way of   telegraphic transfer in immediately available funds to the Seller’s Account,   together with interest thereon at the Agreed Rate for the period from the   Completion Date to the date of the actual payment (both dates inclusive),   which payment shall take effect as an adjustment, by way of increase, in the   Completion Payment.
  
	
  
 
  	
  
 
  
	
  
3.4
  	
  
Within five   (5) Business Days of agreement or determination of the Cash, the Debt, the   Intra-Group Payables, the Intra-Group Receivables and the Working Capital, in   accordance with the provisions of clause 7, and subject to clause 3.6:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
the Seller,   if and to the extent that the Working Capital is more than two million euros   (€ 2,000,000) less than the Reference Working Capital, shall pay, or as the   case may be, repay in cash an amount equal to the amount by which the Working   Capital is less than the sum of (Reference Working Capital - € 2,000,000), by   way of telegraphic transfer in immediately available funds to the Buyer’s   Account, together with interest thereon at the Agreed Rate for the period   from the Completion Date to the date of the actual payment (both dates   inclusive), which payment shall take effect as an adjustment, by way of   reduction, in the Completion Payment; and
  
	
   
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Buyer,   if and to the extent that the Working Capital is more than two million euros   (€ 2,000,000) greater than the Reference Working Capital, shall pay in cash   an amount equal to the amount by which the Working Capital exceeds the sum of   (Reference Working Capital + € 2,000,000), by way of telegraphic transfer in   immediately available funds to the Seller’s Account, together with interest   thereon at the Agreed Rate for the period from the Completion Date to the   date of the actual payment (both dates inclusive), which payment shall take   effect as an adjustment, by way of increase, in the Completion Payment.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.5
  	
  
If any sum   due for payment under or in accordance with this Agreement by one Party to   another is not paid on the due date, the Party in default shall pay interest   thereon (at the same time as payment is made) at the Default Rate for the   period from the due date to the date of actual payment (both dates   inclusive).
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.6
  	
  
Any payment   due from the Buyer to the Seller (or any member of the Seller’s Group) under   clauses 3.2, 3.3 and 3.4 in respect of a particular Group Company shall be   set-off against any payments due from the Seller (or any member of the   Seller’s Group) to the Buyer (or a member of the Group) in respect of the   same Group Company under those clauses.
  
	
   
  	
  
 
  	
  
 
  
	
  
3.7
  	
  
Any payment   due from the Buyer to the Seller (or any member of the Seller’s Group) under   this clause 3 shall be paid to the Seller on the Seller’s Account, and the   Seller shall receive such payment(s) for itself and on behalf of the relevant   member(s) of the Seller’s Group. Receipt of such payment(s) on the Seller’s   Account shall be an effective discharge of the Buyer’s (and the relevant   member(s) of the Buyer’s Group’s (including any Group Company)) obligation to   make or procure the making of such payment(s) and the Buyer shall not be   concerned to see that the payment(s) into the Seller’s Account are applied in   paying any other member of the Seller’s Group.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.8
  	
  
Any payment   due from the Seller (or any member of the Seller’s Group) to the Buyer (or   any member of the Buyer’s Group, including any Group Company) under this   clause 3 shall be paid by the Seller (for itself and on behalf of the   relevant member(s) of the Seller’s Group), to the Buyer’s Account, and the   Buyer shall receive such payment(s) for itself and on behalf of the relevant   member(s) of the Buyer’s Group (including any Group Company). Receipt of any   payment due from the Seller (or any member of the Seller’s Group) to the   Buyer’s Account shall be an effective discharge of the Seller’s (and the   relevant member(s) of the Seller’s Group’s) obligation to make or procure the   making of such payment(s) and the Seller shall not be concerned to see that   the payment(s) into the Buyer’s Account are applied in paying any other member   of the Buyer’s Group (including any Group
Company).
  

12

	
  
4.
  	
  
CONDITIONS PRECEDENT
  
	
  
 
  	
  
 
  
	
  
4.1
  	
  
The   Completion is conditional upon the fulfilment of the Buyer obtaining the   Anti-Trust Clearances in Portugal and Spain (the “Conditions Precedent”).
  
	
  
 
  	
  
 
  	
  
 
  
	
  
4.2
  	
  
The Buyer   agrees to:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
within two   (2) Business Days as from the date of this Agreement, and at its own   expenses, make full and accurate filings with the relevant authorities in   Portugal and Spain with respect to the Contemplated Transaction in order to   obtain the Anti-Trust Clearances and to keep the Seller regularly informed of   the processing of these filings;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
inform   promptly the Seller if it becomes aware of anything that could prevent any of   the Anti-Trust Clearances being obtained;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
provide   without delay the Seller with all documents and information concerning the   filings referred to above, together with any additional and documentary   material that may be requested by the Portuguese or Spanish relevant authorities   in connection with the Anti-Trust Clearances;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
give notice   without delay to the Seller of the satisfaction of any of the Conditions   Precedent (including, copy of the relevant Anti-Trust Clearances as soon as   received from the relevant authority) and, in any event, at the latest by the   time period set out in clause 4.4 below; and more generally,
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
do its best   efforts to ensure the satisfaction of the Conditions Precedent within the   time period required by this Agreement.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
4.3
  	
  
The Seller   agrees to fully co-operate and to cause the relevant Companies and   Subsidiaries to co-operate with the Buyer, upon its request, in providing to   the Buyer and the Buyer’s advisors such assistance as is reasonably necessary   for the Buyer to make the relevant filings referred to under clause 4.2   above; it being agreed that the satisfaction of the Conditions Precedent   shall be the final responsibility and obligation of the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
4.4
  	
  
(a)
  	
  
If the   Conditions Precedent are not fulfilled at the latest by 30 July 2004, at   midnight, as a result of an act or omission or failure by the Buyer, or   waived by the Buyer at its sole discretion, to the extent permitted by law,   then the Seller shall have the right, at its sole discretion, to either: (i)   defer the Completion to 31 August 2004, or (ii) terminate this Agreement. If   the Seller decides to terminate this Agreement, then this Agreement, except   clauses 16, 17 and 27, shall automatically become null and void without any   liability attaching to either Party (except in the event of breach of the   terms and conditions of clause 16). If the Seller decides to defer the   Completion at 31 August 2004, then the Buyer hereby agrees to be bound by   such decision and to proceed to Completion on such date.
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
If the Conditions   Precedent are not fulfilled at the latest by 30 July 2004, at midnight, for   any other reason than as a result of an act or omission or failure by the   Buyer, or waived by the Buyer at its sole discretion, to the extent permitted   by law, then the Parties agree to defer automatically the Completion to 31   August 2004 and therefore to proceed to Completion on such date.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
If the   Conditions Precedent are not fulfilled at the latest by 31 August 2004, then,   during a period of two (2) Business Days following 31 August 2004, the   Parties will discuss in good faith the terms and conditions for postponing   Completion to a later date. If no agreement is reached between the Parties   during such two (2) Business Days period, then the Seller shall have the right,   at its sole discretion, to terminate this Agreement. If the Seller decides to   terminate this Agreement, then this Agreement, except clauses 16, 17 and 27,   shall automatically become null and void without any liability attaching to   either Party (except in the event of breach of the terms and conditions of   clause 16).
  

13

	
   
  	
  
(d)
  	
  
In the event   that Completion takes place on 31 August 2004 pursuant to either clause   4.4(a) or clause 4.4(b), then the Parties agree that the definition of   Reference Working Capital set out in clause 1.1 above shall read as follows:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
““Reference Working Capital” shall mean:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
the amount   of three million three hundred eighty six thousand euros (€ 3,386,000) in the   event that the 2004 edition of the Spanish “Vademecum” directory is published   by MediMedia Medicom SA before the Completion Date and its related revenues   are recognised on or prior to the Completion Date; or
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
the amount   of minus one million three hundred fourteen thousand euros (- €1,314,000) in   the event that the 2004 edition of the Spanish “Vademecum” directory is not   published by MediMedia Medicom SA before the Completion Date and its related   revenues are not recognised on/prior to the Completion Date.”
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
5.
  	
  
ACTIONS BY THE PARTIES PRIOR TO THE COMPLETION DATE
  
	
  
 
  	
  
 
  
	
  
5.1
  	
  
Actions by   the Seller prior to the Completion Date
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
The Seller   shall notify to the Buyer, by no later than five (5) days prior to the   Completion Date, with:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
the   Estimated Cash;
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
the   Estimated Debt;
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
(iii)
  	
  
the   Estimated Intra-Group Payables;
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(iv)
  	
  
the   Estimated Intra-Group Receivables; and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(v)
  	
  
on the basis   of the Estimated Cash, the Estimated Debt, the Estimated Intra-Group Payables   and the Estimated Intra-Group Receivables, the amount of the Completion   Payment to be paid by the Buyer to the Seller in accordance with clause   6.3(e).
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(b)
  	
  
The Buyer acknowledges   and agrees that as from the date of this Agreement prior to Completion, the   actions listed under schedule K will be performed between certain   members of the Seller’s Group and any relevant Group Companies. The Seller   will keep the Buyer regularly informed of the taking of these actions and of   their completion and will provide to the Buyer, for its information and upon   its request, with the agreements (including drafts thereof) to be entered   into in connection with these actions. The Seller shall procure that all   necessary steps are taken to ensure fulfilment of these actions.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
The Seller   hereby agrees to indemnify and hold harmless the Buyer from and against any   Claim resulting from financial, legal and Tax (including, for the avoidance   of doubt, any Tax arising by reason of s. 104-520 of the Australian Income   Tax Assessment Act 1997) consequences of the actions to be performed by the   Seller as listed under schedule K; being however agreed by the Parties   that, for the purposes of this clause 5.1(c):
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
(i)
  	
  
the   provisions of schedule T shall not apply;
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
subject to   sub-paragraph (iii) below, no liability (whether in contract, tort or   otherwise) shall attach to the Seller in respect of any Claim made on account   of this clause 5.1(c) and the Seller shall have no liability of payment   towards the Buyer under this clause 5.1(c) to the extent that such Claim or   the events giving rise to the Claim would not have arisen on but for an act,   omission or transaction of the Buyer’s Group otherwise than in the ordinary   and proper course of the business of the Group as at present carried on and   the Buyer ought reasonably to have been aware that the Claim would not have   arisen but for such act, omission or transaction (other than a Claim which   arises as a result of an act, omission or transaction which was required to   be done or omitted to be done by virtue of this Agreement or any contract or   obligation which any member of the Group entered into prior to Completion);
  

14

	
   
  	
  
 
  	
  
(iii)
  	
  
in respect   of any Claim made by the Buyer on account of this clause 5.1(c) in respect of   any Tax arising from the action set out in schedule K, item 2, (being,   the sale by MediMedia Australia Pty Ltd of its entire equity interest in   Health Communication Network Ltd) (the “HCN   Transaction”), the Seller shall have no liability of payment   towards the Buyer to the extent that the Buyer has not complied with its   undertakings set out in clause 9.11 of this Agreement, provided the Seller   shall have complied with its undertaking set out under clause 5.1(d) below.   In the event of an Authorized Exception, the Buyer will be released from its   undertakings under clause 9.11 below and the Seller will hold the Buyer   harmless from any Tax liability triggered by the HCN Transaction as such Tax   liability shall have been identified in the Buyer’s Tax advisor advice   mentioned in clause 9.11 below (the “HCN   Tax
Liabilities”). In such case, without this being meant to   either limit in any way whatsoever the aforementioned release of the Buyer’s   undertakings or to create any obligation for the Buyer, the Buyer will review   in good faith (with the assistance, as the case may be, of its Tax advisor)   the possibility to implement the roll over relief set out in option “D” of   the Ernst &Young letter dated 7 April 2004 (a copy of which has been   disclosed to the Buyer and is attached to the Disclosure Letter). It is   furthermore expressly agreed that both the Buyer’s Tax advisor and the   Seller’s Tax advisor will be authorized to consult with each other in order   to come up on a best effort basis and in good faith with a solution suitable   for both Parties so as to mitigate the adverse consequences of the HCN   Transaction. Should the Parties agree to follow the solution thus identified,   then the Seller shall be released from its obligations under this clause
5.1(c)(iii). For the avoidance of doubt, should the Buyer decide not to   follow the above-mentioned option “D” on the basis of the afore-mentioned   written advice issued by the Buyer’s Tax advisor, then the Seller’s   obligation to hold the Buyer harmless from any HCN Tax Liabilities triggered   by the HCN Transaction shall remain valid.
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
The Seller   shall notify to the Buyer, by not later than twenty (20) Business Days prior   to the Completion Date, the list of actions to be followed by the Buyer   (including a precise description thereof, a detailed timeline and the   relevant contact information of the Seller’s Tax advisor in charge of this   matter) pursuant to clause 5.1(c)(iii) and clause 9.11 (the “Tax Action List”). The Tax Action List   shall be supported by written advice issued by the Seller’s Tax advisor, a   copy of which shall also be notified to the Buyer within the above   time-period.
  
	
  
 
  	
  
 
  
	
  
5.2
  	
  
Actions by   the Buyer prior to the Completion Date
  
	
  
 
  	
  
 
  
	
  
 
  	
  
With the   full co-operation of the Seller, which, as far as the Seller is capable to,   shall cause the relevant Companies and Subsidiaries to co-operate with the   Buyer, the Buyer shall file the following notifications; it being agreed that   the filing of these notifications shall be the final responsibility and   obligation of the Buyer:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
in Korea:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
filing of a   notification of change of control of MediMedia Korea Ltd with a Foreign   Exchange Bank designated by the Ministry of Commerce, Industry and Energy;   and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
filing of an   anti-trust notification with the Fair Trade Commission; and
  

15

	
  
 
  	
  
(b)
  	
  
in   Australia: filing of a notification of change of control of MediMedia Holding   Australia Pty with the Foreign Investment Review Board.
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
5.3
  	
  
Additional   Disclosures
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
On or before   five (5) Business Days prior to the Completion Date, the Seller will have the   right to disclose to the Buyer any Additional Disclosure(s). Such Additional   Disclosure(s) will relieve the Seller from its liabilities towards the Buyer   under clause 11, providing that the Additional Disclosure(s) (or as series of   Additional Disclosures having the same cause or the same origins or effects),   may not give rise, in aggregate, to a loss (prejudice)exceeding the amount of two million   eight hundred and twenty-five thousand euros (€ 2,825,000).
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
If the   Additional Disclosure(s) (or as series of Additional Disclosures having the   same cause or the same origins or effects) made by the Seller may give rise,   in aggregate, to a loss (préjudice)exceeding the amount of two million   eight hundred and twenty-five thousand euros (€ 2,825,000) and that the   Seller notifies simultaneously the Buyer that such Additional Disclosure(s)   will relieve the Seller’s liabilities under clause 11, then, the Buyer,   promptly and in any event by no later than the Completion Date, will notify   to the Seller:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
its consent,   in which case, for the avoidance of doubt, the Seller will be relieved of its   liabilities of payment under this Agreement in respect of such Additional   Disclosure(s); or
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
(ii)
  	
  
its   disagreement (such disagreement to be reasonably motivated), in which case,   providing that the Parties, acting in good faith, do not settle amicably this   disagreement by no later than the Completion Date, then this Agreement   (except clauses 16, 17 and 27) will automatically be terminated with no   liability attaching to each Party, except in the event of a breach of the   terms and conditions of clause 16.
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
The Buyer’s   consent referred to under paragraph (b) above will be deemed to be granted if   the Buyer fails to notify its disagreement within the time period referred to   above in this paragraph (b).
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
5.4
  	
  
Assignment   of certain Intra-Group Agreements
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
The Seller   will co-operate with the Buyer, if so requested by the Buyer upon reasonable   prior notice, with a view to assign to the Buyer (or its designee) on the   Completion Date all or part of the intercompany loan agreements listed in schedule   L of the Agreement; provided that these assignments can validly be   executed and performed under applicable laws and regulations and/or do not   trigger any adverse financial (including, Tax) consequences for the Seller’s   Group, other than reasonable expenses incurred in respect of such   co-operation.
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
6.
  	
  
COMPLETION
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
6.1
  	
  
Without   prejudice to the provisions of clause 4.4 above, Completion shall occur at   the offices of the Seller’s Advisor on 30 July 2004.
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
6.2
  	
  
On the   Completion Date, subject to the fulfilment by the Buyer of the provisions of   clause 6.3 below, the Seller shall:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
deliver to   the Buyer the Warranties’ Statement executed by the Seller;
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
procure that   the relevant members of the Seller’s Group and of the Group terminate the   Intra-Group Agreements with effect as at the Completion Date at the latest;
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
deliver   evidence of the release of the Security Documents with effect by no later   than the Completion Date;
  

16

	
  
 
  	
  
(d)
  	
  
deliver to   (or procure (se porte fort)to be delivered to) the Buyer the documents listed under schedule   G;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
deliver to   the Buyer the Transitional Services Agreements executed by MediMedia Support   EURL and Doyma;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
deliver to   the Buyer the Licence Agreements executed by The StayWell Company d/b/a   Krames and Oxney Information BV, as appropriate; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(g)
  	
  
(for itself   and on behalf of the relevant member(s) of the Seller’s Group) make or   procure (se porte fort)the discharge and repayment in cash by the relevant   members of the Seller’s Group of the Estimated Intra-Group Receivables, which   are expressed to be payable at Completion, to the Buyer’s Account, by way of   telegraphic transfer in immediately available funds, and the Buyer shall   receive such payments for itself and on behalf of the relevant member(s) of   the Buyer’s Group (including any Group Company). Receipt by the Buyer of such   payments in the Buyer’s Account shall be an effective discharge of the   Seller’s (and the relevant member(s) of the Seller’s Group’s) obligation to   make or procure the making of such payments and the Seller (and the relevant   member(s) of the Seller’s Group) shall not be concerned to see that the   payments into the Buyer’s Account are applied in
paying any other member of   the Buyer’s Group (including any Group Company).
  
	
   
  	
  
 
  	
  
 
  
	
  
6.3
  	
  
On the   Completion Date, the Buyer shall:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
deliver to   the Seller the Warranties’ Statement executed by the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
deliver to   the Seller the documents listed under schedule H;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
deliver to   the Seller executed original copy of the Transitional Services Agreements;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
deliver to   the Seller executed original copy of the Licence Agreements executed by   MediMedia Australia Pty Ltd, MediMedia Pacific Ltd, Vidal SA, MediMedia   International SP Zoo, MediMedia Informations KFT, MediMedia Holding Germany   GmbH and MediMedia Netherlands BV; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
(for itself   and on behalf of the relevant member(s) of the Buyer’s Group (including any   Group Company) make the payment in cash of the Completion Payment and of the   Indian Price, and make or procure (se   porte fort)the discharge and repayment in cash by   the relevant members of the Group of the Estimated Intra-Group Payables,   which are expressed to be payable at Completion, in each case to the Seller’s   Account, by way of telegraphic transfer in immediately available funds, and   the Seller shall receive such payments for itself and on behalf of any   relevant member(s) of the Seller’s Group. Receipt by the Seller of such   payments in the Seller’s Account shall be an effective discharge of the   Buyer’s (and the relevant member(s) of the Buyer’s Group’s) obligation to   make or procure the making of such payments and the Buyer shall not be   concerned to see that the payments into the Seller’s
Account are applied in   paying any other member of the Seller’s Group.
  
	
   
  	
  
 
  	
  
 
  
	
  
6.4
  	
  
On the   Completion Date, the Parties shall allocate the Completion Payment between   each of the Shares in the manner set out in schedule F. For the   avoidance of doubt, such allocation shall not affect in any manner whatsoever   the calculation and determination of the Total Price in accordance with the   provisions of clause 3 above.
  
	
  
 
  	
  
 
  
	
  
7.
  	
  
COMPLETION STATEMENT
  
	
  
 
  	
  
 
  
	
  
7.1 
  	
  
The Seller   shall procure that within sixty (60) Business Days after the Completion Date,   a draft Completion Statement and a draft Completion Accounts setting out:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
the Debt;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Cash;
  

17

	
  
 
  	
  
(c)
  	
  
the   Intra-Group Payables;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
the   Intra-Group Receivables; and
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(e)
  	
  
the Working   Capital;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
as at close   of business on the Completion Date, are prepared in accordance with the   provisions of this clause 7 and more generally, of this Agreement, and a copy   delivered to the Buyer. The Completion Statement and the Completion Accounts   shall be prepared on the basis of the Accounting Policies.
  
	
  
 
  	
  
 
  
	
  
7.2
  	
  
Subject to   clause 7.6(e), the Seller and the Buyer shall each bear their own costs and   expenses (including the fees and expenses of their legal counsel and   accountants) arising out of the preparation and review of the Completion   Statement and the Completion Accounts (and drafts thereof).
  
	
  
 
  	
  
 
  
	
  
7.3
  	
  
The Buyer   shall notify the Seller in writing within thirty (30) Business Days of   receipt of such draft Completion Statement and draft Completion Accounts   whether or not it accepts the draft Completion Statement and draft Completion   Accounts for the purposes of this Agreement.
  
	
   
  	
  
 
  
	
  
7.4
  	
  
If the Buyer   notifies the Seller that it does not accept such draft Completion Statement   and draft Completion Accounts:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
it shall, at   the same time as it notifies the Seller that it does not accept such draft   Completion Statement and draft Completion Accounts, set out in such notice in   writing, together with supporting documentation, its reasons for such   non-acceptance and specify the adjustments which, in its opinion, should be   made to the draft Completion Statement and draft Completion Accounts, and   therefore to the calculation of the Debt and/or the Cash and/or the   Intra-Group Payables and/or the Intra-Group Receivables and/or the Working   Capital, in order to comply with the requirements of this Agreement. All   items which are not specifically disagreed by the Buyer in its notice shall   be deemed to be agreed upon by the Parties for the purposes of this   Agreement; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Buyer   and the Seller shall use all reasonable endeavours to:
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i)
  	
  
meet and   discuss the objections of the Buyer; and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
try to reach   agreement upon the adjustments (if any) required to be made to the draft   Completion Accounts and therefore the draft Completion Statement,
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
in each   case, within twenty (20) Business Days of the Buyer’s notice of   non-acceptance pursuant to clause 7.3 (or such other time as the Buyer and   the Seller may agree in writing).
  
	
   
  	
  
 
  
	
  
7.5
  	
  
If the Buyer   is satisfied with the draft Completion Accounts and the draft Completion   Statement (either as originally submitted by the Seller or after adjustments   agreed between the Seller and the Buyer pursuant to clause 7.4(b) above) or   if the Buyer fails to notify the Seller of its non-acceptance of the draft   Completion Accounts and the draft Completion Statement within the thirty (30)   Business Days period referred to in clause 7.3, then the draft Completion   Accounts and the draft Completion Statement (incorporating any agreed   adjustments) shall constitute the Completion Accounts and the Completion   Statement, and therefore the Debt and/or the Cash and/or the Intra-Group   Payables and/or the Intra-Group Receivables and/or the Working Capital, for   the purposes of this Agreement.
  
	
  
 
  	
  
 
  
	
  
7.6
  	
  
If the   Seller and the Buyer do not reach agreement within the twenty (20) Business   Day period referred to in clause 7.4(b) (or such other time as the Seller and   the Buyer may agree in writing) then the matters in dispute (and only those)   shall be referred, on the application of either the Seller or the Buyer, for   determination by an independent firm of internationally recognised chartered   accountants to be agreed upon by the Seller and the Buyer or, failing   agreement, to be selected, on the application of either the Seller or the   Buyer, via a “référé”proceeding request, by the President of   the Tribunal de Commerce of Paris (the “Expert”).   The following provisions shall apply to such determination:
  

18

	
  
 
  	
  
(a)
  	
  
the Buyer   and/or the Buyer’s accountants and the Seller and/or the Seller’s accountants   shall each promptly (and in any event within such time frame as reasonably   enables the Expert to make its decision in accordance with the time frame set   down in clause 7.6(b)) prepare and deliver to the Expert a written statement   on the matters in dispute (together with the relevant documents, including   the draft Completion Accounts and the draft Completion Statement and the   notice sent by the Buyer pursuant to clause 7.4(a) above);
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Expert   shall be requested to give its decision within twenty (20) Business Days (or   such later date as the Expert determines) of confirmation and acknowledgement   by the Expert of its appointment hereunder;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(c)
  	
  
in giving   such determination, the Expert shall state what adjustments (if any) are   necessary to the draft Completion Accounts and the draft Completion Statement   in respect of the matters in dispute in order to comply with the requirements   of this Agreement;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
the Expert   shall act pursuant to the provisions of Article 1592 of the French Code Civil in making any such   determination which shall be final and binding on the Parties (in the absence   of manifest error);
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
each Party   shall bear the costs and expenses of all counsel and other advisers, witnesses   and employees retained by it and the costs and the expenses of the Expert   shall be borne between the Seller and the Buyer in such proportions as the   Expert shall in its discretion determine or, in the absence of any such   determination, equally between the Seller and the Buyer.
  
	
   
  	
  
 
  	
  
 
  
	
  
7.7
  	
  
When the   Seller and the Buyer reach (or pursuant to clause 7.5 are deemed to reach)   agreement on the Completion Accounts and the Completion Statement or when the   Completion Accounts and the Completion Statement are finally determined at   any stage in accordance with the procedures set out in this clause 7:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
the   Completion Accounts and the Completion Statement as so agreed or determined   shall be the Completion Accounts and the Completion Statement for the   purposes of this Agreement and shall be final and binding on the Parties; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Debt,   the Cash, the Intra-Group Payables, the Intra-Group Receivables and the   Working Capital in each case, as at the close of business on the Completion   Date, shall be as set out in the Completion Statement.
  
	
   
  	
  
 
  
	
  
7.8
  	
  
The Seller   shall procure that each member of the Seller’s Group shall, and the Buyer   shall procure that any Group Company and its and their respective directors,   officers, employees and auditors shall, promptly provide each other, their   respective advisers, the Expert, the Buyer’s accountants and the Seller’s   accountants with all information (in their respective possession or control)   relating to the operations of any Group Company, as the case may be,   including access at all reasonable times to all Group employees, books,   records, relevant working papers and files of the auditors of the Group, and   other relevant information and all co-operation and assistance, as may in any   such case be reasonably required to:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
enable the   production of and the review of the Completion Accounts and the Completion   Statement; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
enable the   Expert to determine the Completion Accounts and the Completion Statement.
  
	
   
  	
  
 
  
	
  
 
  	
  
The Seller   and the Buyer hereby authorise each other, their respective advisers and the   Expert to take copies of all information which they have agreed to provide   under this clause 7.8; provided that the Seller and the Buyer shall instruct   the Expert to keep such information confidential.
  

19

	
  
7.9 
  	
  
The   Completion Accounts and the Completion Statement shall be prepared and shall   be used for the exclusive purpose of determining the Debt, the Cash, the   Intra-Group Receivables, the Intra-Group Payables and the Working Capital as   at the close of business on Completion Date, without any representation or   warranty by either Party with respect to the Completion Accounts and the   Completion Statement.
  
	
  
 
  	
  
 
  
	
  
8.
  	
  
SALE OF THE ATMEDICA INDIAN SHARES
  
	
  
 
  	
  
 
  
	
  8.1
  	
  
Subject to   the Atmedica Indian Consent, the Seller has agreed to sell the Atmedica   Indian Shares to the Buyer and the Buyer has agreed to purchase the Atmedica   Indian Shares for a total price of five hundred thousand euros (€ 500,000)   (the “Indian Price”).
  
	
  
 
  	
  
 
  
	
  
8.2
  	
  
The Seller   will make its best efforts to sell to the Buyer the Atmedica Indian Shares   with effect as at Completion Date as far as possible and, provided that the   Atmedica Indian Consent has been granted, then the Buyer hereby undertakes to   purchase the Atmedica Indian Shares in accordance with the terms and   conditions of this Agreement. The Seller will, as from the date of this   Agreement and in accordance with the provisions of clause 9.2(a) of the   Atmedica Indian Agreement, notify the shareholders of Atmedica Indian Pvt Ltd   of its intention to transfer the Atmedica Indian Shares to the Buyer at the   Indian Price and will ask for the Atmedica Indian Consent.
  
	
  
 
  	
  
 
  
	
  
8.3
  	
  
The Buyer   hereby agrees to take any action, as required under the Atmedica Indian   Agreement and as could be reasonably required by the shareholders of Atmedica   Indian Pvt Ltd, and to co-operate with the Seller, in order to obtain, as   soon as possible, the Atmedica Indian Consent. In particular, the Buyer   hereby agrees to, promptly upon request of the Seller or any shareholder of   Atmedica India Pvt Ltd, execute a counterpart copy of the Atmedica Indian   Agreement and an accession agreement to the Atmedica Indian Agreement in the   form required under the Atmedica Indian Agreement.
  
	
   
  	
  
 
  
	
  
8.4
  	
  
Subject to   the fulfilment of clause 8.2 and clause 8.3, the transfer of the ownership of   the Atmedica Indian Shares by the Seller to the Buyer (the “Indian Completion”) shall take place:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
at the   Completion Date if the Atmedica Indian Consent is granted to the Seller   and/or the Buyer by no later than the Completion Date; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
within five   (5) Business Days as from the date of receipt by the Buyer of a copy of the   Atmedica Indian Consent if the Atmedica Indian Consent is granted after the   Completion Date.
  
	
  
 
  	
  
 
  
	
   
  	
  
At the date   of the Indian Completion, the Seller shall deliver (or cause to be delivered)   to the Buyer the documents listed under clause 3.17 of schedule G.
  
	
  
 
  	
  
 
  
	
  
8.5
  	
  
In the event   that:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
the Atmedica   Indian Consent is refused prior to the Completion Date, then the Buyer shall   not pay the Indian Price at the Completion Date as provided for under clause   6.3(e); or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
the Atmedica   Indian Consent is refused after the Completion Date, then, within five (5)   Business Days after receipt of such notice of refusal, the Seller shall refund   in cash the Indian Price in the Buyer’s Account, by way of telegraphic   transfer in immediately available funds, together with interest thereon at   the Agreed Rate for the period from the Completion Date to the date of the   actual payment (both dates inclusive).
  
	
   
  	
  
 
  
	
  
9.
  	
  
POST COMPLETION UNDERTAKINGS OF THE PARTIES
  
	
  
 
  	
  
 
  
	
  
9.1 
  	
  
Upon   Completion, the Buyer shall and shall procure that any of the Group Companies   shall:
  

20

	
  
 
  	
  
(a)
  	
  
cease in any   manner whatsoever to use, or display the Retained Trademarks, and for that   purpose, take any action required and fully co-operate with the Seller’s   Group to ensure that any of the Retained Trademarks ceases to be used by,   and/or displayed, and/or registered under the name of, any Group Company as   soon as possible after Completion Date and in any event by no later than six   (6) months as from the Completion Date; and
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(b)
  	
  
as soon as   legally possible under the applicable laws and in any event by no later than   ninety (90) days following the Completion Date, procure that those Group   Companies whose corporate names include the word “MediMedia” or the word   “Atmedica” change their respective name so as not to include the   word MediMedia  or Atmedica or any   other word or words confusing similar thereto, and immediately following such   change, give notice to the Seller with supporting evidence; it being agreed   however that Atmedica Malaysia will, as required by applicable law, have to   show its former name (being Atmedica Malaysia) on all documents for a period   of not less than twelve (12) months as from the date of the change of its   corporate name in accordance with this paragraph.
  
	
  
 
  	
  
 
  
	
  
9.2
  	
  
Upon   Completion, the Seller shall and shall procure that any of the member of the   Seller’s Group shall cease in any manner whatsoever to use, or display, any   of the trademarks owned or used (but excluding the trademarks used by any   Group Company pursuant to the Licence Agreements or any other licence   agreements (or similar arrangements) entered into with a Third Party) by any   Group Company and, that does not fall within the Retained Trademarks   definition, and for that purpose, take any action required and fully   co-operate with any such Group Company, to ensure that all of these   trademarks ceases to be used by, and/or displayed, and/or registered under   the name of, any member of the Seller’s Group (including, where such   trademarks are predominantly used by a Group Company, by assigning the rights   over those trademarks to the relevant Group Company as indicated by the   Buyer) as soon as possible after Completion Date and in any
event by no later   than six (6) months as from the Completion Date.
  
	
   
  	
  
 
  
	
  
9.3
  	
  
The Buyer   acknowledges and agrees (on its behalf and on behalf of any Group Company)   that upon Completion, all insurance coverage provided in relation to the   business and affairs (including, the Business) of any Group Company pursuant   to policies maintained by any of the Seller or any member of the Seller’s   Group (whether such policies are maintained with Third Party insurers or with   the Seller or the Seller’s Group) shall cease, at no cost for the Group, and   no further coverage shall be available to any Group Company under any such   policies.
  
	
  
 
  	
  
 
  
	
  
9.4
  	
  
The Buyer   acknowledges and agrees (on its behalf and on behalf of any Group Company)   that upon Completion (but save as otherwise provided in this Agreement and in   particular under the Transitional Services Agreements and the Licence   Agreement), contracts, agreements, and other arrangements entered into   between any Group Company on one hand, and any member of the Seller’s Group   on the other hand (including the Intra-Group Agreements) will be terminated,   at no cost for the Group, with effect as from Completion Date, except for   those contracts, agreements, and other arrangements entered into, in the   ordinary course of business, for the supply of general services.
  
	
  
 
  	
  
 
  
	
  
9.5
  	
  
The Buyer   undertakes to use all reasonable endeavours to obtain, at no costs to the   Seller or any member of the Seller’s Group, promptly after the Completion   Date, the release of any member of the Seller’s Group from all guarantees,   letters of comfort or similar undertakings given by any of them to Third   Parties in connection with any obligation of any of the Companies or   Subsidiaries, including but not limited to those set out in the Disclosure   Letter (the “Guarantees”). In   the event that any claim is made by a Third Party against any member of the   Seller’s Group under any such Guarantees, the Buyer shall promptly indemnify   and keep indemnified the relevant member of the Seller’s Group of any cost,   charges or other expenses incurred by the relevant member of the Seller’s   Group.
  

21

	
  
9.6
  	
  
The Seller   undertakes to use all reasonable endeavours to obtain, at no cost to the   Buyer or any Group Company, promptly after the Completion Date, the release   of any member of the Group, from all guarantees, letters of comfort or   similar undertakings given by any of them to Third Parties in connection with   any obligation of any of the Seller’s Group, including but not limited to   those set out in the Disclosure Letter. In the event that any claim is made   by a Third Party against any member of the Group under any such guarantee,   letter of comfort or similar undertaking, the Seller shall promptly indemnify   and keep indemnified the relevant member of the Group of any cost, charges or   other expenses incurred by the Buyer or any relevant member of the Group or,   as the case may be, Atmedica India Pvt Ltd.
  
	
  
 
  	
  
 
  
	
  
9.7
  	
  
Each Party   will give the other Party (subject to customary confidentiality undertakings)   reasonable co-operation, access (including the right to take copies at the   own costs of the requiring Party), and staff assistance, as needed, during   normal business hours, with respect to books of account, books, records,   accounts, other financial data, or records relating to the Business,   employees, Tax matters or operations of the Group in the period up to the   Completion, held directly or indirectly by such Party, and relating to the   Group Companies (the “Records”), except   to the extent such access is restricted by law or the terms of any agreement,   as may be necessary for such requiring Party (i) to prepare its Tax returns   and financial statements, (ii) to manage and handle its Tax or social   security audits or investigations, (iii) to handle any insurance claim, legal   proceedings, employees claims or investigations by any
governmental or   regulatory body.
  
	
   
  	
  
 
  
	
  
9.8
  	
  
The   undertakings contained in clause 9.7 above will survive until the later of   (i) the expiry of a period of three (3) years from the Completion Date (plus   any additional time during which a Party has been advised that there is an   on-going Tax or social security (or equivalent) audit with respect to periods   prior to the Completion, or such period is otherwise open to assessment) or   (ii) the expiry of the applicable law or regulations to retain the Records,   and to an extent as will not interfere with the disclosing Party’s conduct of   its business.
  
	
  
 
  	
  
 
  
	
  
9.9
  	
  
The Seller   (on its behalf and on behalf of any member of the Seller’s Group) and the   Buyer (on its behalf and on behalf of any member of the Buyer’s Group,   including the Group) agree to keep the Records reasonably accessible, and not   to destroy or otherwise dispose of the Records (and any copies of the   Records) for the duration provided for under clause 9.8 above without the   prior written consent of the other Party (which shall have the opportunity to   remove and retain any of the Records at its own costs).
  
	
  
 
  	
  
 
  
	
  
9.10
  	
  
As from the   Completion Date and as long as the Buyer will have any rights of payment   against the Seller under clause 11 (but subject, as the case may be, to schedule   T) of this Agreement, in the event that, following (i) the disposal by   the Seller of any of its assets or (ii) a distribution of cash or repayment   of subordinated debt or loans or preferred shares by the Seller to the   ultimate shareholders of the Seller’s Group, (a “Seller’s Transaction”), then the Seller will provide the   Buyer, by no later than two (2) days prior to the completion of a Seller’s   Transaction, with a certificate prepared by its auditors (the “Value Certificate”) confirming that the   Seller’s Group Value (computed on the basis of the latest estimate of the   EBITDA of the remaining Seller’s Group after completion of said Seller’s   Transaction and, in respect of the Net Financial Debt, calculated on a
pro   forma basis of the remaining Seller’s Group after completion of said Seller’s   Transaction) of the remaining Seller’s Group resulting from the said Seller’s   Transaction exceeds: (i) one hundred million euros (€ 100,000,000), if such   Seller’s Transaction is to take place between the period as from the   Completion Date and up to 31 December 2005; or (ii) fifty million euros (€   50,000,000) plus the amount of outstanding Claims notified by the Buyer prior   to 31 December 2005, if such Seller’s Transaction is to take place between   the period as from 1 January 2006 and up to 31 December 2007; or (iii)   twenty-five million euros (€ 25,000,000) plus the amount of outstanding   Claims notified by the Buyer prior tol31 December 2007, if such Seller’s   Transaction is to take place between the period as from 1 January 2008 and up   to 30 July 2011 (or up to such later date on which any outstanding Claims   made under clause 11 of this Agreement
have been settled in accordance with   this Agreement). Upon receipt of any Value Certificate, the Buyer undertakes   to take no action with a view to interfere with a Seller’s Transaction.
  

22

	
  
 
  	
  
In the event   that a Value Certificate states that the Seller’s Group Value (computed on   the basis of the latest estimate of the EBITDA of the remaining Seller’s   Group after completion of a Seller’s Transaction and, in respect of the Net   Financial Debt, calculated on a pro forma basis of the remaining Seller’s   Group after completion of a Seller’s Transaction) of the remaining Seller’s   Group resulting from a Seller’s Transaction, is less than: (i) one hundred   million euros (€ 100,000,000), if a Seller’s Transaction is to take place   between the period as from the Completion Date and up to 31 December 2005; or   (ii) fifty million euros (€ 50,000,000) plus the amount of outstanding Claims   notified by the Buyer prior to 31 December 2005, if such Seller’s Transaction   is to take place between the period as from 1 January 2006 and up to 31   December 2007; or (iii) twenty-five million euros (€
25,000,000) plus the   amount of outstanding Claims notified by the Buyer prior to 31 December 2007,   if such Seller’s Transaction is to take place between the period as from 1   January 2008 and up to 30 July 2011 (or up to such later date on which any   outstanding Claims made under clause 11 of this Agreement have been settled   in accordance with this Agreement), then, the Seller will deliver to the   Buyer, at the latest at the date of completion of the relevant Seller’s   Transaction, either: (i) a bank guarantee (“caution   bancaire solidaire”)issued   by a first rank bank, with no “benéfice de   discussion et de division” and for the relevant amounts provided   for under clause 3.1 and then, clause 3.2 and then, clause 3.3 of schedule   T, in all cases as appropriate depending on the date of such delivery; or   (ii) any other similar undertaking to be agreed between the Buyer and the   Seller (such delivery being confirmed in writing
together with the delivery   of the relevant Value Certificate).
  
	
   
  	
  
 
  
	
  
 
  	
  
For the   avoidance of doubt, upon delivery of any bank guarantee or such other agreed   undertaking under this clause 9.10, the Seller will be automatically released   from its obligations under this clause 9.10; except if such bank guarantee or   such other agreed undertaking lapses before 30 July 2011, or if later, the   date on which any outstanding Claims made under clause 11 of this Agreement   have been settled in accordance with this Agreement.
  
	
  
 
  	
  
 
  
	
  
9.11
  	
  
Without   prejudice to clause 5.1(d) of the Agreement, the Buyer undertakes and shall   procure (se porte fort)that MediMedia Australia Pty Ltd and   MediMedia Holding Australia Pty undertake, to comply with the Tax Action List   except where the Buyer’s Tax advisor shall have notified in writing prior to   the Completion Date (with a copy to the Seller) that the Tax Action List   either (i) is not workable or not practicable without exposing, directly or   indirectly, the Buyer to significant irrecoverable costs or (ii) is likely to   have an adverse net Tax impact whether actual or contingent (such impact not   to include the total or partial unavailability of the loss incurred by the   liquidation of Medical Observer Pty Ltd) for MediMedia Holding Australia Pty   Ltd, MediMedia Australia Pty Ltd or the Substituted Buyer in Australia (but   in respect of the latter only to the extent of a net Tax impact suffered or   likely to be suffered as a direct
result of a Tax impact affecting MediMedia   Holding Australia Pty Ltd or MediMedia Australia Pty Ltd) (an “Authorized Exception”).
  
	
   
  	
  
 
  
	
  
10.
  	
  
COVENANT UP TO COMPLETION
  
	
  
 
  	
  
 
  
	
  
10.1
  	
  
As from the   date of this Agreement and pending Completion, and except as contemplated in schedule   K and in schedule R (including all of the actions necessary to   implement the transactions contemplated under schedule K and schedule   R) and, more generally, in this Agreement, or with the prior written   consent of the Buyer (such consent not to be unreasonably withheld or   delayed) or if required by law or other mandatory obligation or, as disclosed   in the Disclosure Letter, contractual obligation, the Seller shall and, as   far as legally possible, shall procure that the Group Companies shall (in   each case in relation to the Business):
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
carry out   their Business in the ordinary course of business and manage their Business “en bon   père de famille”;or
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(b)
  	
  
not amend   their by-laws or take any action which would result in amending their   by-laws; or
  

23

	
  
 
  	
  
(c)
  	
  
not   implement merger or legal reorganisations or legal restructuring or, except   in the ordinary course of business, cease trading any part of their Business;   or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
not enter   into any material contract or commitment involving an actual expenditure for   the relevant Company or Subsidiary in excess of two hundred thousand euros (€   200,000) over a period of one (1) year or which is not in the ordinary course   of trading; or
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(e)
  	
  
not dispose   of any part of the Business except in the ordinary course of trading; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
not permit   any of its insurance policy to lapse or not do anything which will make any   insurance police void or voidable; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(g)
  	
  
not grant or   create any Encumbrance over the Shares and, as the case may be, the Atmedica   Indian Shares, or over their Assets; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(h)
  	
  
not enter   into any leasing, hire purchase or other agreement or arrangements for   payment on deferred terms other than in the ordinary course of business; or
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(i)
  	
  
except as   required pursuant to the applicable collective bargaining agreements or local   equivalent agreements, make any material change in the terms and conditions   of employment, including deciding a general increase in the remuneration of   the employees; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(j)
  	
  
not borrow   any money from a Third Party for an amount in excess of one hundred thousand   euros (€ 100,000) or other than in the ordinary course of business; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(k)
  	
  
not declare,   make or pay any dividend, reserves or payment of interim dividends or other   distribution to a Third Party or a member of the Seller’s Group; or
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(l)
  	
  
not amend   the Accounting Policies; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(m)
  	
  
not give any   guarantees to a Third Party except in the ordinary course of business; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(n)
  	
  
not create,   allot or issue any share or loan capital in any Group Company or acquire   shares in any other Third Party; or
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(o)
  	
  
not repay   redeem or agree to repay or redeem any shares of their capital or loan   capital, and not agree or agreed to effect any reduction of their issued share   capital, or purchased their own shares; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(p)
  	
  
not assign,   transfer, licence any Intellectual Property to a Third Party or a member of   the Seller’s Group or not grant any Encumbrance over any Intellectual   Property; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(q)
  	
  
except as   otherwise provided in this Agreement and save in respect of the approval of   annual accounts or the appointment or discharge of directors or statutory   auditors, not pass any resolution of its shareholders, whether in general   meeting or otherwise; or
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(r)
  	
  
other than   in the ordinary course of business, not enter into any contract providing for   unusual trade discounts or unusual other special terms; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(s)
  	
  
issue   invoices with their trade debtors in line with historic practice; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(t)
  	
  
except as   indicated under schedule C in respect of those Subsidiaries which are,   at the date of this Agreement, under a liquidation process or under external   administration or other similar proceedings, not file any petition or convene   any meeting for the winding-up of any Group Company or for the appointment of   any provisional liquidator, and not file any petition for an administration   order to be made in relation to any Group Company and for the appointment of   any receiver (including, without limitation, any administrative receiver) in   respect of the whole or any part of the property, assets and/or undertaking   of any Group Company; or
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(u)
  	
  
not agree,   conditionally or otherwise, to do any of the foregoing.
  

24

	
  
10.2
  	
  
Notice of   any change
  
	
  
 
  	
  
 
  
	
  
 
  	
  
In the event   that any of the event listed in clause 10.1 is contemplated by the Seller or   by a Group Company, between the date of this Agreement and the Completion   Date, the Seller shall, promptly as such event arises or becomes known to it,   notify the Buyer of any such event. Within five (5) Business Days as from the   date of the Seller’s notice referred to above, the Buyer shall have the right   to object in writing to such event, together with reasonable supporting   grounds. The Buyer’s consent to an event will be deemed granted if the Buyer   fails to disapprove it within the five (5) Business Days period referred   above.
  
	
   
  	
  
 
  
	
  
11.
  	
  
WARRANTIES OF THE SELLER
  
	
  
 
  	
  
 
  
	
  
11.1
  	
  
The Seller   warrants, as at the date of this Agreement and, subject to the Warranties’   Statement, as at the Completion Date (but save with respect to clause 14 of schedule   S), to the Buyer in terms of the Warranties of the Seller and each of the   Warranties of the Seller shall be separate and independent and construed as a   separate Warranty of the Seller. The Seller warrants to the Buyer no other   statement than the Warranties of the Seller.
  
	
  
 
  	
  
 
  
	
  
11.2
  	
  
Subject to   clauses 11.3 to 11.4 below, the Seller shall pay to the Buyer the amount of   any Claim which arises from any of the Warranties of the Seller being untrue   or breached, or from any breach of the covenants of the Seller arising from   clause 10, and the Parties agree that such amount shall be equal to the   amount necessary to put the Buyer into the position which would have existed   if the relevant Warranty of the Seller had not been untrue or breached or if   the relevant covenant of the Seller had not been breached.
  
	
  
 
  	
  
 
  
	
  11.3
  	
  
Any Claim   and any payment by the Seller under a Claim is subject to the terms and   provisions of this clause 11 and of schedule T.
  
	
  
 
  	
  
 
  
	
  
11.4
  	
  
The Seller   shall be under no liability under any of the Warranties of the Seller in   relation to any matter forming the subject matter of a Claim thereunder to   the extent that the same or circumstances giving rise thereto are fairly   disclosed in the Disclosure Letter or in the Disclosed Information and/or in   the Warranties’ Statement and/or in this Agreement; provided however that any   matter disclosed in the Disclosed information and/or the Disclosure Letter   and/or the Warranties’ Statement and triggering a loss (préjudice) relating to Tax shall not   discharge the Seller from its liabilities under (and subject to) this clause   11 and schedule T.
  
	
  
 
  	
  
 
  
	
  
11.5
  	
  
Save in the   case of fraud or wilful concealment by any Group Company or any of its   officers or employees, the Seller: (i) hereby irrevocably waives any and all   claims against each such Group Company and any of its officers or employees   and (ii) undertakes (if any Claim is made against it in connection with the   sale of the Shares to the Buyer) not to make any claim against any such   person on whom it may have relied before agreement to any terms of this   Agreement or authorising any statement in the Disclosure Letter (and   undertakes that no member of the Seller’s Group claiming under or through it   will make any such claim).
  
	
   
  	
  
 
  
	
  
12.
  	
  
WARRANTIES OF THE BUYER
  
	
  
 
  	
  
 
  
	
  
12.1
  	
  
The Buyer   hereby represents and warrants to the Seller as of the date hereof and as of   the Completion Date as follows (the “Warranties   of the Buyer”):
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
Corporate   Organisation
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
The Buyer is   a private limited company validly organised and existing under the laws of   England and has all requisite corporate power and authority to enter into the   Agreement and any other documents to be entered into pursuant to the   Agreement and to perform its obligations hereunder.
  

25

	
  
 
  	
  
(b)
  	
  
Authorisation   and Validity
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
Subject to   the fulfilment of the Conditions Precedent, the execution and delivery of the   Agreement and the performance by the Buyer of the Contemplated Transaction   have been duly authorised by all necessary corporate action and any other   consents required by the Buyer have been obtained. This Agreement has been   duly executed by the Buyer, and subject to the fulfilment of the Conditions   Precedent, this Agreement constitutes a valid and binding agreement of the   Buyer, enforceable against the Buyer in accordance with the terms hereof.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
No Conflict   or Violation
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
The   performance of the Contemplated Transaction herein will not: (i) violate or   conflict with the constitutive documents of the Buyer or (ii) violate or   constitute a default under any material contract to which the Buyer is a   party or by which its assets or property are bound or any law or regulation   or any order, judgement or rule of any judicial, governmental or regulatory   authority which is applicable to the Buyer or its respective assets or   property.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
Third Party   Consents
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
Unless   otherwise provided in this Agreement with respect to the acquisition by the   Buyer of the Atmedica Indian Shares, no Third Party consents other than   provided for in clauses 4.1 and 5.2 above are required to be made or obtained   by the Buyer in connection with the execution and delivery of this Agreement,   or the performance of the Contemplated Transaction.
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
Acknowledgement
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
The Buyer   declares that on the basis of the (i) Disclosed Information and, (ii)   publicly available information, and (iii) information otherwise available to   it, it has carried out its own reasonable investigation in, and analysis of,   relevant local laws applicable to the Group (including Atmedica India Pvt   Ltd) and in particular, as regards, restrictions on foreign investments.
  
	
  
 
  	
  
 
  
	
  
12.2
  	
  
The Buyer   shall pay to the Seller the amounts of any claim which arises from any of the   Warranties of the Buyer being untrue or breached and the Parties agree that   such amounts shall be equal to the amounts necessary to put the Seller into   the position which would have existed if the Warranties of the Buyer had been   true and complete.
  
	
   
  	
  
 
  
	
  
12.3
  	
  
If any sum   payable by the Buyer to the Seller under this clause 12 shall be subject to   Tax (whether by way of deduction or withholding or direct assessment by any   Tax authority of the person entitled thereto), such payment shall be   increased by such an amount as shall ensure that after deduction, withholding   or payment of such Tax (and after taking into account any relief to which the   recipient is entitled to as result of such withholding or deduction), the   Seller shall have received a net amount equal to the payment otherwise required   to be made by the Buyer under this clause 12.
  
	
  
 
  	
  
 
  
	
  
12.4
  	
  
Save in the   case of fraud or wilful concealment by any of the Buyer’s officers or   employees, the Seller (i) hereby irrevocably waives any and all claims   against any of the Buyer’s officers or employees and (ii) undertakes (if any   claim is made against it in connection with the purchase of the Shares from   the Seller) not to make any claim against any such person on whom it may have   relied before agreement to any terms of this Agreement (and undertakes that   no member of the Seller’s Group claiming under or through it will make any   such claim).
  
	
  
 
  	
  
 
  
	
  
13.
  	
  
ACCESS TO INFORMATION
  
	
   
  	
  
 
  
	
  
13.1
  	
  
The Buyer   expressly acknowledges and agrees that prior to the execution of this   Agreement, it, along with its advisers, carried out a due diligence of the   Group (including Atmedica India Pvt Ltd) and for that purposes, was allowed   access to the Disclosed Information. In this respect, the Buyer acknowledges   and agrees that it has been in a position to review the contents of the   Disclosed Information, in particular by asking any question which the   analysis of the Disclosed Information might entail and by questioning the   relevant directors, officers, employees and advisers of the Seller’s Group or   any Group Company, the names of which are set out in schedule P.
  

26

	
  
13.2
  	
  
Save as   otherwise provided in this Agreement, any Disclosed Information supplied by   or on behalf of any Group Company (including Atmedica India Pvt Ltd) to or on   behalf of the Seller or the Seller’s Group shall not constitute a   representation or warranty or guarantee as to the accuracy thereof by the   Seller or the Seller’s Group (or any of their respective directors, officers,   employees and advisers) and shall not in any manner whatsoever lead to any   liability or obligation by the Seller or the Seller’s Group or any of their   respective directors, officers, employees and advisers. Consequently, the   Buyer undertakes (on its behalf and on behalf of the Buyer’s Group) to any   member of the Seller’s Group (for themselves and any of their respective   directors, officers, employees and advisers) that it will not bring any   claims against such persons in respect thereof.
  
	
   
  	
  
 
  
	
  
14.
  	
  
NON-SOLICITATION
  
	
  
 
  	
  
 
  
	
  
14.1
  	
  
The Seller   shall not and shall procure, as far as it is legally capable to, that the   members of the Seller’s Group shall not, during a period of eighteen (18)   months from the Completion Date, solicit, approach, canvass or hire, directly   or indirectly, in any manner whatsoever, any director, officer, senior executives   (cadres)or manager of the Group; provided that   nothing in this clause 14.1 shall prohibit any member of the Seller’s Group   from making general advertisements for positions.
  
	
  
 
  	
  
 
  
	
  
14.2
  	
  
The Seller   shall pay to the Buyer the amount of any claim which arises from any breach   by the Seller of this clause 14.1 and the Parties agree that such amount   shall be equal to the amount necessary to put the Buyer in the position which   would have existed if the provisions of clause 14.1 had not been breached.
  
	
  
 
  	
  
 
  
	
  15.
  	
  
NON COMPETITION
  
	
  
 
  	
  
 
  
	
  
15.1
  	
  
Unless   otherwise agreed under clause 15.2, the Seller covenants and procures, as far   as it is legally capable to, that the members of the Seller’s Group covenant   as if they were parties covenanting with the Buyer in the same terms, that   for a period of two (2) years after the Completion Date, they will not:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
carry out   either on their own account or in conjunction with or on behalf of any Third   Party, or be engaged, concerned or interested, directly or indirectly,   whether as shareholder, director, partner, agent or otherwise, in carrying   out, in France, Spain, Portugal, Belgium, The Netherlands, Germany, Hungary,   Poland, Russia, Australia, New Zealand, the Peoples’ Republic of China, Hong   Kong, India (but only as from, and subject to, the Indian Completion),   Bangladesh, Indonesia, Korea, Malaysia, The Philippines, Singapore, Taiwan,   Thailand and Vietnam, any business (other than as a holder of shares in a   company carrying on such a Business where the shareholding is for investment   purposes only and does not confer any control over the business in question)   which competes with the activities of compiling, distributing and marketing   by all methods and means (in particular directories, CD Roms, the internet or   other media) of drug databases
which in particular include the name and   monograph of drugs including active substances and the form of dosage, such   databases intended for sale or distribution free of charge to professionals   in the health industry (doctors, pharmacists, hospitals, students,   physicians...) and to insurance companies, as such activities are carried out   by the relevant Group Companies as at the Completion Date;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
carry out   either on their own account or in conjunction with or on behalf of any Third   Party, or be engaged, concerned or interested, directly or indirectly,   whether as shareholder, director, partner, agent or otherwise, in carrying   out, in Belgium, The Netherlands, Germany, Australia, Peoples’ Republic of   China, Hong Kong,
  

27

	
  
 
  	
  
 
  	
  
Bangladesh,   Indonesia, Korea, Malaysia, New Zealand, The Philippines, Singapore, Taiwan,   Thailand and Vietnam, any business (other than as a holder of shares or   equity interest in a company carrying on such a Business where the   shareholding is for investment purposes only and does not confer any control   over the business in question) which competes with the activities of editing,   publishing, selling or distributing the “Healthcare professionals’ trade   magazine” defined as being professional journals sold or distributed free of   charge, primarily for the benefit of doctors, dentists, vets and pharmacists,   as such activities are carried out by the relevant Group Companies.
  
	
   
  	
  
 
  
	
  
15.2
  	
  
Nothing in   this clause 15.1 shall prevent or restrict the Seller or any other member of   the Seller’s Group from, after the Completion Date, within any of the   jurisdictions referred to under clause 15.1(a) or (b), as appropriate:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
carrying out   either on their own account or in conjunction with or on behalf of any Third   Party, or being engaged, concerned or interested, directly or indirectly,   whether as shareholder, director, partner, agent or otherwise, in carrying   out or being engaged in or economically interested in any business   (including, in France, Spain and Australia, the business of editing,   publishing, selling or distributing the “Healthcare professionals’ trade   magazine” defined as being professional journals sold or distributed free of   charge, primarily for the benefit of doctors, dentists, vets and   pharmacists), which, at the date of this Agreement, it currently carries out   or is engaged in or economically interested in or any reasonable extension or   development thereof;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
carrying out   or being engaged in or economically interested in any of the activities referred   to under clause 15.1 above after such time as the Buyer’s Group ceases to   carry out or be engaged in or economically interested in such activities to   any material extent;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
acquiring   the whole or any part of a business which, or the share capital of a Third   Party or group of Third Parties whose business or a part thereof, competes   with the activities referred to under clause 15.1 above (the “Competitive Operations”),as part of a larger acquisition or   series of related acquisitions provided that such acquisition has not been   made with the sole or main purpose of acquiring the Competitive Operations;   and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
trading with   its existing customers or any future customers provided that, save as   authorised under clause 15.2(b) above, such trading does not constitute a   breach of the provisions of clause 15.1 above.
  
	
  
 
  	
  
 
  
	
  
15.3
  	
  
The Seller   shall pay to the Buyer the amount of any claim which arises from any breach   of the covenants by the Seller under this clause 15 and the Parties agree   that such amount shall be equal to the amount necessary to put the Buyer in   the position which would have existed if the covenants of the Seller had not   been breached.
  
	
   
  	
  
 
  
	
  
16.
  	
  
ANNOUNCEMENTS - CONFIDENTIALITY - CONFIDENTIAL INFORMATION
  
	
  
 
  	
  
 
  
	
  
16.1
  	
  
Pending   Completion to the date five (5) years from Completion, no Party shall   disclose the making of this Agreement nor its terms nor any other agreement   referred to in this Agreement (except those matters set out in the press   release to be prior agreed between the Parties) without the prior written   consent of the other Party unless disclosure is:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
to its   advisers; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
required for   the Atmedica Indian Consent; or
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
required by   law, rule or regulation or regulatory, administrative or government body and   such disclosure shall then only be made by that Party:
  

28

	
  
 
  	
  
 
  	
  
(i)
  	
  
after it has   taken all such steps as may be reasonable in the circumstances to agree the   contents of such announcement with the other Parties before making such   announcement and provided that any such announcement shall be made only after   notice sent reasonably in advance to the other Parties; and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
(ii) 
  	
  
to the   person or persons and in the manner required by law, rule or regulation or   regulatory, administrative or government body or as otherwise agreed between   the Parties.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
For the   avoidance of doubt, nothing herein shall be deemed to prohibit or restrict   the Seller from disclosing information to (i) any member of the Seller’s   Group (including their respective directors, officers and employees), (ii)   the lending banks of the Seller’s Group and (iii) to the employees of any   Group Company as may be required by applicable laws or regulations or other   contractual undertakings.
  
	
  
 
  	
  
 
  
	
  
16.2
  	
  
The Seller   covenants and procures that the members of the Seller’s Group covenant that   they will not at any time hereafter disclose to any Third Party any   confidential information relating to the internal management and Business   operations of any Group Company and the identity of their customers,   products, finances, contractual arrangement, business or methods of business   as known by the Seller prior to the Completion Date. This covenant does not   however apply to:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
disclosure   of confidential information required to be disclosed or divulged by law or by   court or by any administrative or regulatory body;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
confidential   information which becomes generally known by the public or any Third Party   other than by the Seller’s breach of clause 16.2; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
disclosure   of confidential information to professional advisers for the purpose of   advising any member of the Seller’s Group.
  
	
  
 
  	
  
 
  
	
  17.
  	
  
COSTS
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Unless   expressly otherwise provided in this Agreement, each of the Parties shall   bear its own costs, charges, and other expenses (including, inter alia, its   legal, accountancy and other costs, charges and expenses) connected with the   negotiation, preparation and performance of this Agreement, it being   specified that the Buyer expressly agrees to bear any transfer tax or stamp   tax duty (or similar) in respect of the acquisition of the France Shares (as   referred to Article 726 under the French Code   Général des Impôts),the   Spain Shares and each of the Santémedia Shares (including, as the case may   be, the Atmedica Indian Shares), if any.
  
	
  
 
  	
  
 
  
	
  
18.
  	
  
ASSIGNMENT
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Unless   otherwise provided in this Agreement, this Agreement is personal to the   Parties and accordingly no Party without the prior written consent of the   others (such consent not to be unreasonably withheld) shall assign or   transfer, the benefit of all or any of any other Party’s obligations nor any   benefit arising under this Agreement neither shall any Party delegate any of   its obligations under this Agreement or subcontract their provision to any   Third Party; provided that the rights and benefits of the Parties under this   Agreement (including, for the avoidance of doubt, the Warranties of the   Seller or the Warranties of the Buyer, as appropriate, and any causes of   action arising with any of them) may be assigned by each Party to a member of   their respective group (which, for the avoidance of doubt, shall include the   UBM Group and the Seller’s Group) but always so that if such assignee ceases   to be a member of that group, then
such rights or benefits shall be assigned   to another member of that group.
  

29

	
  
19.
  	
  
FURTHER ASSURANCES
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Each of the   Parties shall from time to time upon request from the others do or procure   the doing of all acts and/or execute or procure the execution of all such   documents in so far as each is reasonably able and (unless otherwise agreed   between the Parties) in a form reasonably satisfactory to the Party concerned   for the purpose of transferring to the Buyer the Shares, the Atmedica Indian   Shares, and otherwise giving the other Parties the full benefit of this   Agreement.
  
	
  
 
  	
  
 
  
	
  
20.
  	
  
WAIVER
  
	
  
 
  	
  
 
  
	
  20.1
  	
  
A waiver of   any term, provision or condition of, or consent granted under, this Agreement   shall be effective only if given in writing and signed by the waiving or   consenting Party and then only in the instance and for the purpose for which   it is given.
  
	
  
 
  	
  
 
  
	
  
20.2
  	
  
No failure   or delay on the part of any Party in exercising any right, power or privilege   under this Agreement shall operate as a waiver thereof, nor shall any single   or partial exercise of any such right, power or privilege preclude any other   or further exercise thereof or the exercise of any other right, power or   privilege.
  
	
  
 
  	
  
 
  
	
  
20.3
  	
  
No breach of   any provision of this Agreement shall be waived or discharged except with the   express written consent of the Seller and the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
21.
  	
  
INVALIDITY
  	
  
 
  
	
   
  	
  
 
  
	
  
21.1
  	
  
If any   provision of this Agreement is or becomes invalid, illegal, inapplicable or   unenforceable, the validity, legality, applicability and enforceability of   this Agreement shall not be affected or impaired in any way.
  
	
  
 
  	
  
 
  
	
  
21.2
  	
  
In such an   event, the Parties will negotiate in good faith and promptly in order to   substitute, if possible, the relevant invalid, illegal, inapplicable or   unenforceable provision with a valid, legal, applicable and enforceable provision   corresponding to the original provision.
  
	
  
 
  	
  
 
  
	
  
22.
  	
  
NOTICES
  
	
  
 
  	
  
 
  
	
  
22.1
  	
  
All notices,   demand or other communication given or made under or in connection with the   matters contemplated by this Agreement shall only be effective if made in   writing and sent by registered letter with acknowledgement of receipt, or by   facsimile confirmed on the same day by registered letter with acknowledgement   of receipt, or by personal delivery with acknowledgement of receipt:
  
	
   
  	
  
 
  
	
  
 
  	
  
in the case   of the Seller:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Santémedia   Holding S.à r.l.
  
	
  
 
  	
  
5, Parc   d’Activité Syrdall, L-5365 Münsbach, Luxembourg.
  
	
  
 
  	
  
Fax: 00 352   26 94 12 81
  
	
  
 
  	
  
Attention:   Mr Marcus Wood and Mr François Mirallié
  
	
  
 
  	
  
 
  
	
  
 
  	
  
with a copy   to:
  
	
  
 
  	
  
 
  
	
   
  	
  
MediMedia SA
  
	
  
 
  	
  
12, rue   d’Uzés, 75002 Paris - France
  
	
  
 
  	
  
Fax: 00 33 140 13 40 17
  
	
  
 
  	
  
Attention:   Mr François Mirallié and Mrs Marie-Michéle Blouin
  

30

	
  
 
  	
  
with a copy   to:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Ashurst
  
	
  
 
  	
  
22 rue de   Marignan, 75008 Paris - France
  
	
   
  	
  
Fax: 00 33 1   53 53 53 54
  
	
  
 
  	
  
Attention:   Maître Nathalie Alibert;
  
	
  
 
  	
  
 
  
	
  
 
  	
  
in the case   of the Buyer:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
United   Business Media Group Limited
  
	
  
 
  	
  
Ludgate   House, 245 Blackfriars Road
  
	
  
 
  	
  
London SE1   9UY - United Kingdom
  
	
  
 
  	
  
Fax: 00 44   207 928 2728
  
	
  
 
  	
  
Attention:   Anne Siddell (Company Secretarial Department)
  
	
   
  	
  
 
  
	
  
 
  	
  
with a copy   to:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Allen &   Overy Llp
  
	
  
 
  	
  
26, boulevard   des Capucines, 75009 Paris - France
  
	
  
 
  	
  
Fax: 00 33 1   40 06 54 54
  
	
  
 
  	
  
Attention:   Maître Jean-Claude Rivalland
  
	
  
 
  	
  
 
  
	
  
 
  	
  
and shall be   deemed to have been duly given or made as follows:
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
if sent by   registered letter with acknowledgement of receipt, two (2) Business Days   after the date of posting;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
if sent by   facsimile, the next Business Day following such despatched;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
if   personally delivered, upon delivery at the address of the relevant party;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
provided   that if, in accordance with the above provisions, any such notice, demand or   other communication would otherwise be deemed to be given or made outside   9.00 a.m. - 5.00 p.m. on a Business Day such notice, demand or other   communication shall be deemed to be given or made at 9.00 a.m. on the next   Business Day.
  
	
   
  	
  
 
  
	
  
22.2
  	
  
A Party may   notify the other Party to this Agreement of a change to its name, relevant   addressee, address or fax number for the purposes of clause 22.1 provided   that such notification shall only be effective:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
on the date   specified in the notification as the date on which the change is to take   place; or
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
if no date   is specified or the date specified is less than five (5) Business Days after   the date on which notice is given, the date falling five (5) Business Days   after notice of any such change has been given.
  
	
  
 
  	
  
 
  
	
  23.
  	
  
SUBSTITUTION OF THE BUYER
  
	
  
 
  	
  
 
  
	
  
 
  	
  
The Buyer   shall be entitled, subject to prior written notice addressed to the Seller by   no later than ten (10) Business Days prior to the Completion Date (such notice   including a brief description of the Substituted Buyer(s), as defined below,   together with details of the Shares to be purchased by the Substituted   Buyer(s)) to have the purchase of the Shares completed by one or more   companies set up by the Buyer or any member of the Buyers’ Group prior to the   Completion Date (the “Substituted Buyer”);provided that:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
each   Substituted Buyer purchases the relevant Shares as described in the aforesaid   notice; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
each   Substituted Buyer executes those relevant documents which are required to be   executed by the Buyer under this Agreement as at the Completion Date; and
  

31

	
  
 
  	
  
(c)
  	
  
the Buyer   shall remain jointly and severally liable with each of the Substituted Buyers   for any of the obligations and liabilities of the Buyer under this Agreement.
  
	
  
 
  	
  
 
  
	
  
24.
  	
  
SCHEDULES
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Each of the   schedules to this Agreement forms an integral part of this Agreement and   references to this Agreement shall, unless the context otherwise requires,   include references to the schedules.
  
	
  
 
  	
  
 
  
	
  
25.
  	
  
AMENDMENTS
  
	
   
  	
  
 
  
	
  
 
  	
  
Any   amendment to this Agreement (including to any of its schedules) must be made   in writing and signed by each of the Parties.
  
	
  
 
  	
  
 
  
	
  
26.
  	
  
ENTIRE AGREEMENT
  
	
  
 
  	
  
 
  
	
  
 
  	
  
This   Agreement together with any other documents referred to in this Agreement   shall constitute the entire and only agreement between the Parties.   Consequently, this Agreement supersedes any contract, agreement, exchange of   letters or verbal agreement relating to the Contemplated Transaction and that   might have been entered into between the Parties prior to the date of this   Agreement.
  
	
  
 
  	
  
 
  
	
  
27.
  	
  
GOVERNING LAW - JURISDICTION
  
	
  
 
  	
  
 
  
	
  27.1
  	
  
This   Agreement shall be governed by and construed in accordance with French law.
  
	
  
 
  	
  
 
  
	
  
27.2
  	
  
Any dispute,   controversy, proceedings or claim of whatever nature arising out of or in any   way relating to this Agreement (or any matters contemplated under this   Agreement) or its formation or its validity or its interpretation or its performance shall be definitively   resolved according to the arbitration rules of the ICC by one or more   arbitrators, appointed in accordance with the ICC rules. The arbitration   shall take place in Paris and the arbitration language shall be English; it   being agreed that documents in French (including, for example, case law)   could be exchanged or delivered without translation in English.
  
	
  
 
  
	
  
Made in   Paris, on 16 June 2004, in two (2) originals.
  

	
  
For the   Seller:
  	
  
 
  	
  
For the   Buyer:
  
	
   
  	
  
 
  	
  
 
  
	
  
/s/ FRANÇOLS MIRALLIÉ
  	
  
 
  	
  
/s/ NIGELWILSON
  
	
  

  	
  
 
  	
  

  
	
  
Santémedia   Holding S.à r.l.
  	
  
 
  	
  
United   Business Media Group Limited
  
	
  
Represented   by Mr Françols Mirallié 
  	
  
 
  	
  
Represented   by UNM Investments Limited
  
	
  
Title: Gérant
  	
  
 
  	
  
Title:   Director
  
	
  
 
  	
  
 
  	
  
Represented   by: Nigel Wilson
  
	
   
  	
  
 
  	
  
Title:   Director of UNM Investments Limited
  

32

LIST OF SCHEDULES

	
  
SCHEDULE A:
  	
  
The   Santémedia Shares and the Santémedia Beneficial Ownership
  
	
  
 
  	
  
 
  
	
  
SCHEDULE B:
  	
  
The   Companies
  
	
  
 
  	
  
 
  
	
  
SCHEDULE C:
  	
  
The   Subsidiaries
  
	
  
 
  	
  
 
  
	
  
SCHEDULE D:
  	
  
Accounting   Policies
  
	
   
  	
  
 
  
	
  
SCHEDULE E:
  	
  
Draft Completion   Statement
  
	
  
 
  	
  
 
  
	
  
SCHEDULE F:
  	
  
Amount of   the Completion Payment for the France Shares, the Spain Shares and the   Australian Shares
  
	
  
 
  	
  
 
  
	
  
SCHEDULE G:
  	
  
List of   documents to be delivered to the Buyer by the Seller pursuant to clause   6.2(c)
  
	
  
 
  	
  
 
  
	
  
SCHEDULE H:
  	
  
List of   documents to be delivered by the Buyer to the Seller pursuant to clause   6.3(a)
  
	
  
 
  	
  
 
  
	
  
SCHEDULE I:
  	
  
Form of the   letters of resignation
  
	
   
  	
  
 
  
	
  
SCHEDULE J:
  	
  
Agreed form   of transfer agreements
  
	
  
 
  	
  
 
  
	
  
SCHEDULE K:
  	
  
Actions to   be performed by the Seller prior to the Completion Date
  
	
  
 
  	
  
 
  
	
  
SCHEDULE L:
  	
  
Intra-Group   Agreements
  
	
  
 
  	
  
 
  
	
  
SCHEDULE M:
  	
  
Security   Documents
  
	
  
 
  	
  
 
  
	
  
SCHEDULE N:
  	
  
Retained   Trademarks
  
	
  
 
  	
  
 
  
	
  SCHEDULE O:
  	
  
Transitional   Services Agreement
  
	
  
 
  	
  
 
  
	
  
SCHEDULE P:
  	
  
List of the   directors or employees for the purpose of clause 13.1
  
	
  
 
  	
  
 
  
	
  
SCHEDULE Q:
  	
  
Licence   Agreements
  
	
  
 
  	
  
 
  
	
  
SCHEDULE R:
  	
  
Authorised   actions
  
	
  
 
  	
  
 
  
	
  
SCHEDULE S:
  	
  
Warranties   of the Seller
  
	
  
 
  	
  
 
  
	
  
SCHEDULE T:
  	
  
Seller   Protection Clauses
  
	
   
  	
  
 
  
	
  
SCHEDULE U:
  	
  
Key   Employees of the Group
  
	
  
 
  	
  
 
  
	
  
SCHEDULE V:
  	
  
Debt, Cash   and Working Capital Definitions
  

33

SCHEDULE A

	
  
A.
  	
  
THE SANTEMEDIA SHARES
  
	
  
 
  	
  
 
  
	
  
 
  	
  
For the   purposes of this Agreement, the Santémedia Shares means the following shares   of the Companies listed below (as such Companies are described under schedule   B) owned by the Seller:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
1.
  	
  
eighty three   thousand five hundred (83,500) shares, representing together one hundred per   cent. (100%), of the share capital of MediMedia Belgium SA;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
2.
  	
  
one (1)   share, representing one hundred per cent. (100%), of the share capital of   MediMedia Holding Germany GmbH;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
3.
  	
  
four hundred   and one (401) shares, representing together one hundred per cent. (100%), of   the share capital of MediMedia Netherlands BV;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
4.
  	
  
five   thousand (5,000) shares, representing together one hundred per cent. (100%),   of the share capital of Livros Technicos Portugeses LTP SA;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
5.
  	
  
one hundred   (100) shares, representing together one hundred per cent. (100%), of the   share capital of MediMedia International SP Zoo;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
6.
  	
  
seven   million nine hundred thousand eight hundred ninety two (7,900,892) shares,   representing together one hundred per cent. (100%), of the share capital of   MediMedia Holding Australia Pty;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
7.
  	
  
one thousand   eight hundred (1,800) shares, representing together one hundred per cent.   (100%), of the share capital of MediMedia (NZ) Ltd;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
8.
  	
  
four   thousand eight hundred ninety six (4,896) shares, representing together 48.96   per cent., of the share capital of Infopharma Media Services;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
9.
  	
  
one (1)   share of MediMarketing Inc.;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
10.
  	
  
nine hundred   ninety nine (999) shares, representing together 99.90 per cent., of the share   capital of MediMedia Pacific Lltd;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
11.
  	
  
fifteen   million two hundred fifty thousand (15,250,000) shares, representing together   one hundred per cent. (100%), of the share capital of MediMedia Asia Pte Ltd;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
12.
  	
  
three   hundred twenty thousand (320,000) shares, representing together one hundred   per cent. (100%), of the share capital of MediMedia Korea Chusik Hosea.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
B
  	
  
THE SANTEMEDIA BENEFICIAL OWNERSHIP
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
For the purposes   of this Agreement, the Santémedia Beneficial Ownership means the following   beneficial ownership of the shares of the Companies listed below (as such   Companies are described under schedule B) held by the Seller:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
1.
  	
  
the   beneficial ownership of forty four thousand nine hundred ninety nine (44,999)   shares, representing together approximately thirty per cent. (30%) of the   share capital of MediMarketing Inc.;
  

34

	
  
 
  	
  
2.
  	
  
the   beneficial ownership of two hundred fifty thousand (250,000) shares of   Atmedica Malaysia (M) Sdn Bhd;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
3.
  	
  
the   beneficial ownership of two thousand six hundred (2,600) shares, representing   one hundred per cent. (100%) of the share capital of PT Infomaster;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
4.
  	
  
the   beneficial ownership of ten thousand (10,000) shares, representing together   one hundred per cent. (100%) of the share capital of MediProm (Malaysia) Sdn   Bhd;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
5.
  	
  
the   beneficial rights and interests in two (2) ordinary shares of par value   s$1.00, representing one hundred percent (100%) of the share capital in   Medidata Pte Ltd; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
6.
  	
  
the   beneficial ownership of one (1) share representing 0.1 per cent. of the share   capital in MediMedia Pacific Ltd.
  

35

SCHEDULE B

THE COMPANIES

36

	
  
1.
  	
  
VIDAL SA, a company organised under the laws   of France, having its registered office at 21-23, rue Camille Desmoulins,   92130 Issy-les-Moulineaux - France.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
MediMedia Medicom SA, a company organised   under the laws of Spain, having its registered office at 90 Calle Infanta   Mercedes, 90, 6th Floor, Madrid - Spain.
  
	
  
 
  	
  
 
  
	
  
3.
  	
  
Livros Technicos Portugueses LTP, a company   organised under the laws of Portugal, having its registered office at Avenida   Visconde de Valmor, n° 65-1° Andar, Lisboa - Portugal.
  
	
  
 
  	
  
 
  
	
  4.
  	
  
MediMedia Belgium SA, a company organised   under the laws of Belgium, having its registered office at 100, rue de   Bourdon, B-1180 UCCLE (Brussels) - Belgium.
  
	
  
 
  	
  
 
  
	
  
5.
  	
  
MediMedia Holding Germany GmbH, a company   organised under the laws of Germany, having its registered office at Am   Forsthaus, Gravenbruch 7, 63263 Neu - Isenburg - Germany.
  
	
  
 
  	
  
 
  
	
  
6.
  	
  
MediMedia Netherlands, a company organised   under the laws of the Netherlands, having its registered office at   Transistorstraat 44 I, 1322 CG Almere - The Netherlands.
  
	
  
 
  	
  
 
  
	
  
7.
  	
  
MediMedia International SP Zoo, a company   organised under the laws of Poland, having its registered office at Plac   Bankowy 2, Blue Tower 00 - 095 Warsaw - Poland.
  
	
  
 
  	
  
 
  
	
  
8.
  	
  
MediMedia Holding Australia Pty Ltd, a   company organised under the laws of Australia, having its registered office   at 2nd Floor, 1-9 Chandos Street, Crows Nest NSW Australia 2065.
  
	
   
  	
  
 
  
	
  
9.
  	
  
MediMedia NZ Ltd, a company organised under   the laws of New Zealand, having its registered office at 3 Shea Terrace   Takapuna North Shore City - New Zealand.
  
	
  
 
  	
  
 
  
	
  
10.
  	
  
MediMedia Pacific Ltd, a company organised   under the laws of Hong Kong, having its registered office at Unit 901-903, 9th   floor AXA center, 151 Gloucester Road, Wan Chai - Hong Kong.
  
	
  
 
  	
  
 
  
	
  
11.
  	
  
PT Infomaster, a company organised under the   laws of Indonesia, having its registered office at Wisma Pondok Indah LT 2,   Suite 202-A, Jalan Sultan Iskandar Muda V-TA, Jakarta Seletan 12310 -   Indonesia.
  
	
  
 
  	
  
 
  
	
  
12.
  	
  
MediMedia Korea Chusik Hoesa, a company   organised under the laws of Korea, having its registered office at c/o 4th   floor, BMS Building, 829-1 Yeoksam-Dong, Gangnam-Gu, Seoul1 35-936.0 - Korea.
  
	
   
  	
  
 
  
	
  
13.
  	
  
MediProm (Malaysia) SDN BHD, a company   organised under the laws of Malaysia, having its registered office at 41B   Damai Complex, Jalan Dato Haji Eusoff, 50400 Kuala Lumpur - Malaysia.
  
	
  
 
  	
  
 
  
	
  
14.
  	
  
Atmedica (M) SDN BHD, a company organised   under the laws of Malaysia, having its registered office at 41B Damai   Complex, Jalan Dato Haji Eusoff, 50400 Kuala Lumpur - Malaysia.
  
	
  
 
  	
  
 
  
	
  
15.
  	
  
MediMedia Asia Pte Limited, a company   organised under the laws of Singapore, having its registered office at 3 Lim   Teck Kim Road n°10-01, Singapore Technologies Building, Singapore 088934.
  
	
  
 
  	
  
 
  
	
  
16.
  	
  
MediData Pte Ltd, a company organised under   the laws of Singapore, having its registered office at 200 Cantonment Road n°02-03,   Southpoint, Singapore 089763.
  
	
   
  	
  
 
  
	
  
17.
  	
  
Infopharma Media Services, a company   organised under the laws of Thailand, having its registered office at No. 368   Sukhumvit 68, Sukhumvit Road, Kwaeng Bangna, Khet Bangna, Bangkok 10260 -   Thailand.
  
	
  
 
  	
  
 
  
	
  
18.
  	
  
MediMarketing Inc., a company organised   under the laws of The Philippines, having its registered office at 28th   Floor, Equitable Bank Tower, 8751 Paseo de Roxas, Makati City 1127 - The   Philippines.
  

37

SCHEDULE C

THE SUBSIDIARIES

38

	
  
1.
  	
  
SUBSIDIARY OF VIDAL SA
  
	
  
 
  	
  
 
  
	
  -
  	
  
Astra Pharma   Services, a company organised under the laws of Russia, having its registered   office at Kalanchevskaya Str.ll, Building #   2, 107078 Moscow - Russia1
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
SUBSIDIARY OF MEDIMEDIA BELGIUM SA
  
	
  
 
  	
  
 
  
	
  
-
  	
  
MediBRIDGE   NV, a company organised under the laws of Belgium, having its registered   office at 100, rue de Bourdon, B-1180 UCCLE (Brussels) - Belgium
  
	
  
 
  	
  
 
  
	
  
3.
  	
  
SUBSIDIARIES OF MEDIMEDIA HOLDING GERMANY GmbH
  
	
  
 
  	
  
 
  
	
  
-
  	
  
MediMedia   Medizinische Medien Information GmbH, a company organised under the laws of   Germany, having its registered office at Am Forsthaus Gravenbruch 7, 63263   Neu-Isenburg - Germany
  
	
   
  	
  
 
  
	
  
-
  	
  
MediMedia   Eastern Europe GmbH, a company organised under the laws of Germany, having   its registered office at Am Forsthaus Gravenbruch 5-7, 63263 Neu-Isenburg -   Germany
  
	
  
 
  	
  
 
  
	
  
-
  	
  
MediMedia   Informations KFT, a company organised under the laws of Hungary, having its   registered office at Thaly Kalman u. 39 1096 Budapest - Hungary
  
	
  
 
  	
  
 
  
	
  
-
  	
  
IMP Verlag   (dormant subsidiary - in process of liquidation), a company organized under   the laws of Austria, having its registered office at Burgerstrasse 2, 6020   Innsbruck - Austria.
  
	
  
 
  	
  
 
  
	
  
4.
  	
  
SUBSIDIARY OF LIVROS TECNICOS PORTUGUESES LTP SA
  
	
  
 
  	
  
 
  
	
  -
  	
  
Edicoes   Simposium LDA, a company organised under the laws of Portugal, having its   registered office at 65-1 Avenida Visconde de Valmor, 1050-239 Lisboa -   Portugal.
  
	
  
 
  	
  
 
  
	
  
5.
  	
  
SUBSIDIARY OF MEDIMEDIA HOLDING AUSTRALIA PTY Ltd
  
	
  
 
  	
  
 
  
	
  
-
  	
  
MediMedia   Australia Pty Ltd, a company organised under the laws of Australia, having its   registered office at 2nd Floor, 1-9 Chandos Street, Crows Nest NSW   - Australia 2065.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Medical   Observer Pty Ltd (under external administration - liquidator appointed), a   company organised under the laws of Australia, having its registered office   at Suite 1, level 1, the Stroll, Howard Avenue, Dee Why NSW - Australia 2099.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Mims Data   Systems (under external administration - liquidator appointed), a company   organised under the laws of Australia, having its registered office at 2nd   Floor, 1-9 Chandos Street, Crows Nest NSW - Australia 2065.
  
	
   
  	
  
 
  
	
  
6.
  	
  
SUBSIDIARIES OF MEDIMEDIA PACIFIC Ltd
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Atmedica   Pacific (in process of liquidation), a company organised under the laws of   Hong Kong.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
MediMedia   Zhuhai Ltd, a company organised under the laws of People’s Republic of China,   having its registered office at Unit 901-903, 9th floor AXA   center, 151 Gloucester Road, Wan Chai - Hong Kong.
  

39

	
  
7.
  	
  
SUBSIDIARIES OF MEDIMEDIA ASIA PTE Ltd
  
	
  
 
  	
  
 
  
	
  -
  	
  
Atmedica   Asia Pte, a company organised under the laws of Singapore, having its   registered office at 3 Lim Teck Kim Road n°10-01, Singapore Technologies   Building - Singapore 088934.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
LPSA Pte Ltd   (former name: Aptitude Systems Pte Ltd) (dormant company), a company   organised under the laws of Singapore, having its registered office at 101   Cecil Street N°25-05, Tong Eng Building - Singapore 069533.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Tradimed Pte   Ltd, a company organised under the laws of Singapore, having its registered   office at 101 Cecil Street N°25-05, Tong Eng Building - Singapore 069533.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Atmedica   Thailand Ltd, a company organised under the laws of Thailand, having its   registered office at 58-60 Sukhumvit 62, Sukhumvit Road, Kwaeng Bangjak, Khet   Prakanong, Bankok 10260 - Thailand.
  
	
  
 
  	
  
 
  
	
  8.
  	
  
SUBSIDIARIES OF MEDIDATA PTE Ltd
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Medidata   Taiwan Ltd, a company organised under the laws of Taiwan, having its   registered office at 8th floor, N° 200, Sec.3, Nanking East Road,   Taipei 104 - Taiwan.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
MediMedia   Thailand Ltd, a company organised under the laws of Thailand, having its   registered office at 58-60 Sukhumvit 62, Sukhumvit Road, Kwaeng Bangjak, Khet   Prakhanong, Bangkok 10260 - Thailand.
  
	
  
 
  	
  
 
  
	
  
-
  	
  
Atmedica   Bangladesh Pvt Ltd, a company organised under the laws of Bangladesh, having   its registered office at “Living Dhupchaya”, Flat 1D 108 Lake Circus Road,   Dhaka 1205, Bangladesh.
  

	
  

  
	
  1
  	
  
NB: the   official office registered at the applicable companies house is 1Hvostoov   per.11-a, Office 423, Moscow, 109180 - Russia. Up-date of the current   registered office detailed above will take several months.
  

40

SCHEDULE D

ACCOUNTING POLICIES

	
  
Part I:
  	
  
Accounting Policies and Procedures for the Completion Statement and   the Completion Accounts
  
	
  
 
  	
  
 
  
	
  
1.
  	
  
The   Completion Statement and the Completion Accounts shall be prepared in accordance   with the policies that are referred to in this clause 1:
  
	
  
 
  	
  
 
  
	
  
1.1
  	
  
the general   accounting policies set out in clause 2 of Part I and so that, in the case of   any conflict, such accounting policies shall override the provisions of   clause 1.2 and 1.3 of Part I;
  
	
   
  	
  
 
  
	
  
1.2
  	
  
subject to   clause 1.1 above, the special purpose accounting principles, practices,   procedures, methods and bases as set out in Part II of this schedule D;
  
	
  
 
  	
  
 
  
	
  
1.3
  	
  
subject to   clause 1.1 and 1.2 of Part I, in accordance with French GAAP.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
General
  
	
  
 
  	
  
 
  
	
  
2.1
  	
  
Materiality
  
	
  
 
  	
  
 
  
	
  
 
  	
  
In preparing   the Completion Statement and the Completion Accounts no minimum materiality   limits shall be applied.
  
	
   
  	
  
 
  
	
  
2.2
  	
  
Nominal   Ledger
  
	
  
 
  	
  
 
  
	
  
 
  	
  
All items to   be included within the Completion Statement will be drawn from the nominal   ledger balances as shown in the books and records of the relevant member of   the Group (for the avoidance of doubt, not the bank statement balances).
  
	
  
 
  	
  
 
  
	
  
Part II:
  	
  
Special purpose accounting principles, practices, procedures, methods   and bases
  

	
  
 
  	
  
(a)
  	
  
Please refer   to the attached special purpose accounting principles, practices, procedures,   methods and bases (being a document of twelve (12) pages).
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
In addition,   in respect of exchange rates, the following principles should be applied:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(i) 
  	
  
for the   purposes of calculating the Working Capital as per schedule V, the   exchange rates to be used should be the budgeted exchange rates; and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
(ii)
  	
  
for the   purpose of calculating the Debt (as per schedule V), the Cash (as per schedule   V), the Intra-Group Payables and the Intra-Group Receivables, the actual   exchange rates as at the Completion Date should be used.
  

41

SCHEDULE E

DRAFT COMPLETION STATEMENT

To: United Business Media Group Limited

[Date]

Dear Sirs,

Agreement dated • 2004 between Santémedia Holding S.à r.l. and UBM (the “Agreement”)

We refer to the Agreement. Terms defined in the Agreement have the same meaning in this statement. This is the Completion Statement as such term is defined in clause 7.1 of the Agreement.

For the purposes of the Agreement:

	
  
the Debt is
  	
  
€ •
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
the Cash is
  	
  
€ •
  	
  
 
  
	
   
  	
  
 
  	
  
 
  
	
  
the   Intra-Group Payables is
  	
  
€ •
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
the   Intra-Group Receivables is
  	
  
€ •
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
the Working   Capital is
  	
  
€ •
  	
  
 
  

	
  
Yours   faithfully,
  	
  
 
  
	
   
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
Santémedia   Holding S.à r.l.
  	
  
 
  
	
  
Mr •
  	
  
 
  
	
  
Title: •
  	
  
 
  

42

SCHEDULE F

ALLOCATION OF THE COMPLETION PAYMENT
 BETWEEN EACH OF THE SHARES

This statement will be completed by the Parties at the Completion Date in accordance with clause 6.4 of the Agreement.

For the avoidance of doubt, the total price for the Atmedica Indian Shares is five hundred thousand euros (€ 500,000) as set out in clause 8.1 of the Agreement.

	
   
  	
  
 
  	
  
Shares of
   each Company
  	
   
 	
  
Completion Payment (in €)
  
	
  
 
  	
  
 
  	
  

  	
   
 	
  

  
	
  
1.
  	
  
 
  	
  
Vidal SA
  	
  
 
  	
  
•
  
	
  
2.
  	
  
 
  	
  
MediMedia   Medicom SA
  	
  
 
  	
  
•
  
	
  
3.
  	
  
 
  	
  
Livros   Technicos Portugueses LTP
  	
  
 
  	
  
•
  
	
  4.
  	
  
 
  	
  
MediMedia   Belgium SA
  	
  
 
  	
  
•
  
	
  
5.
  	
  
 
  	
  
MediMedia   Holding Germany Gmbh
  	
  
 
  	
  
•
  
	
  
6.
  	
  
 
  	
  
MediMedia   Netherlands BV
  	
  
 
  	
  
•
  
	
  
7.
  	
  
 
  	
  
MediMedia   International SP Zoo
  	
  
 
  	
  
•
  
	
  
8.
  	
  
 
  	
  
MediMedia   Holding Australia Pty Ltd
  	
  
 
  	
  
•
  
	
  9.
  	
  
 
  	
  
MediMedia NZ   Ltd
  	
  
 
  	
  
•
  
	
  
10.
  	
  
 
  	
  
MediMedia   Pacific Ltd
  	
  
 
  	
  
•
  
	
  
11.
  	
  
 
  	
  
PT   Infomaster
  	
  
 
  	
  
•
  
	
  
12.
  	
  
 
  	
  
MediMedia   Korea Chusik Hoesa
  	
  
 
  	
  
•
  
	
  
13.
  	
  
 
  	
  
MediProm   Malaysia Sdn Bhd
  	
  
 
  	
  
•
  
	
  14.
  	
  
 
  	
  
Atmedica   Malaysia Sdn Bhd
  	
  
 
  	
  
•
  
	
  
15.
  	
  
 
  	
  
MediMedia   Asia Pte Limited
  	
  
 
  	
  
•
  
	
  
16.
  	
  
 
  	
  
Medidata Pte   Ltd
  	
  
 
  	
  
•
  
	
  
17.
  	
  
 
  	
  
Infopharma   Media Services
  	
  
 
  	
  
•
  
	
  
18.
  	
  
 
  	
  
MediMarketing   Inc
  	
  
 
  	
  
•
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
   
 
	
  
TOTAL
  	
  
 
  	
  
 
  	
  
 
  	
  
•
  

43

SCHEDULE G

LIST OF THE DOCUMENTS TO BE DELIVERED TO THE BUYER
 BY THE SELLER PURSUANT TO CLAUSE 6.2(D)

All of the documents to be delivered by the Seller to the Buyer and listed below shall be dated as at Completion Date.

Documents to be delivered under clause 3.17 of this schedule G shall be delivered (or cause to be delivered) by the Seller to the Buyer on the date of the Indian Completion in accordance with clause 8 of the Agreement.

	
  
1.
  	
  
Documents to be delivered by the Seller on behalf of MMHF:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   minutes evidencing that the transfer of the France Shares to the Buyer has   been prior approved by the board of directors of Vidal SA;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   minutes evidencing that the work council committee (comitéd’entreprise)of Vidal SA has rendered an opinion on   the sale of the France Shares to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of any   share transfer forms evidencing that any shares of Vidal SA held by any   member of the Seller’s Group (via a legal entity or an individual) have been   transferred to MMHF;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(d)
  	
  
copy of   letters of resignation in the agreed form set out in schedule J   executed by MMHF, Masson SAS and MediMedia Support EURL, from their offices   as director (administrateur)of Vidal SA with effect as from the   Completion Date at the latest;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
original/   executed copy of the convention de sortie   d’intégration fiscale entered   into between Vidal SA and MMHF;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
original   share transfer form (ordre de mouvement)in respect of all the France Shares,   signed by MMHF and completed in the name of the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(g)
  	
  
evidence   that the transfer of the France Shares in favour of the Buyer has been   registered in the shareholders’ accounts (comptes   d’actionnaires)and   the share transfer book (registre des   mouvements de titres) of Vidal SA;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(h)
  	
  
original of   the tax transfer form (formulaire cerfa   n°2759 DGI) executed by MMHF in connection with the transfer of   the France Shares to the Buyer; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(i)
  	
  
copy   evidencing the termination of any power of attorney given on the bank   accounts of Vidal SA and its Subsidiaries to the Seller’s Group   representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  2.
  	
  
Documents to be delivered by the Seller on behalf of Doyma:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.1 in respect of   the transfer of the Spain Shares executed by Doyma; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Medicom SA to the   Seller’s Group representatives, as listed in the Disclosure Letter.
  

44

	
  3.
  	
  
Documents to be delivered by the Seller:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.1
  	
  
In respect   of the Company MediMedia Holding Germany GmbH:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.2in respect of the transfer of 1 share   of MediMedia Holding Germany GmbH to the Buyer executed by the Seller;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   letters of resignation in the agreed form set out in schedule I   executed by the Seller’s representatives, from their offices as director of   MediMedia Holding Germany GmbH with effect as from the Completion Date at the   latest;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   letters of resignation in the agreed from set out in schedule I   executed by the Seller’s representatives, from their offices as director of   MediMedia Medizinische Medien Information GmbH (being a Subsidiary) with   effect as from the Completion Date at the latest; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Holding Germany GmbH and   its Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.2
  	
  
In respect   of the Company MediMedia Belgium SA:
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
copy   evidencing the transfer of 83,500 shares of MediMedia Belgium SA to the Buyer   has been registered in the share transfer register of MediMedia Belgium SA;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   letters of resignation in the agreed form set out in schedule I   executed by the Seller’s representatives, from their offices as director of   MediMedia Belgium SA with effect as from the Completion Date at the latest;   and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Belgium SA to the   Seller’s Group representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  
	
  3.3
  	
  
In respect   of the Company Livros Technicos Portugeses LTP SA:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
original of   the stock certificates of Livros Technicos Portugeses LTP SA;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of Livros Technicos Portugeses LTP SA   to the Seller’s Group representatives, as listed in the Disclosure Letter;   and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   Portuguese transfer of shares tax form “Modelo   4”executed by the   Seller.
  
	
   
  	
  
 
  	
  
 
  
	
  
3.4
  	
  
In respect   of the Company MediMedia Netherlands BV:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.3 in respect   of the transfer of 401 shares of MediMedia Netherlands BV to the Buyer executed   by the Seller;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   shareholders’ register of MediMedia Netherlands BV;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   letters of resignation in the agreed form set out in schedule I   executed by the Seller’s representatives, from their offices as director of   MediMedia Netherlands BV with effect as from the Completion Date at the   latest; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Netherlands BV to the   Seller’s Group representatives, as listed in the Disclosure Letter.
  

45

	
  
3.5
  	
  
In respect   of the Company MediMedia International SP Zoo:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.4 in respect   of the transfer of 100 shares of MediMedia International SP Zoo BV to the   Buyer executed by the Seller;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   letters of resignation in the agreed form set out in schedule I   executed by the Seller’s representatives, from their offices as director of   MediMedia International SP Zoo with effect as from the Completion Date at the   latest; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia International SP Zoo to   the Seller’s Group representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.6
  	
  
In respect   of the Company MediMedia Holding Australia Pty:
  
	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
copy of the   minutes of the meeting of the board of directors of MediMedia Holding   Australia Pty approving the transfer of its shares to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   share transfer form evidencing the transfer of 7,900,892 shares of MediMedia   Holding Australia Pty to the Buyer executed by the Seller;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   share certificate of 7,900,892 shares of MediMedia Holding Australia Pty in   the name of the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy of the   letters of resignation in the agreed form set out in schedule I   executed by the Seller’s representatives, from their offices as director of   MediMedia Holding Australia Pty with effect as from the Completion Date at   the latest;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
copy of the   letters of resignation in the agreed form set out in schedule I   executed by the Seller’s representative, from his offices as director of   MediMedia Australia Pty Limited (being a Subsidiary) with effect as from the   Completion Date at the latest;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Holding Australia Pty and   its Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.7
  	
  
In respect   of the Company MediMedia (NZ) Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
copy of the   board resolution of MediMedia (NZ) Ltd approving the transfer of 1,800 shares   of MediMedia (NZ) Ltd by the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   share transfer form for the transfer of 1.800 shares of MediMedia (NZ) Ltd by   the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy   evidencing the registration of the transfer of all the shares of MediMedia   (NZ) Ltd in the company’s share register;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy of the   letter of resignation in the agreed form set out in schedule I   executed by the Seller’s representative, from his offices as director of   MediMedia (NZ) Ltd with effect as from the Completion Date at the latest; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia (NZ) Ltd to the Seller’s   Group representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.8
  	
  
In respect   of the Company Infopharma Media Services Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   minutes of the meeting of the board of directors of Infopharma Media Services   Ltd approving the transfer of 4,896 shares by the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(b)
  	
  
copy of the   share transfer document for the transfer of 4,896 shares of Infopharma Media   Services Ltd by the Seller to the Buyer; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of Infopharma Media Services Ltd to   the Seller’s Group representatives, as listed in the Disclosure Letter.
  

46

	
  
3.9
  	
  
In respect   of the Company MediMarketing Inc.:
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
copy of the   declaration of trust for 44,996 shares of MediMarketing Inc. in favour of the   Buyer executed by Anecita T. Fuentes;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   declaration of trust for 3 shares of MediMarketing Inc. in favour of the   Buyer executed by Renato Z. Francisco;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   deed of assignment for the transfer of one (1) share of MediMarketing Inc. by   the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy of the   written waivers of pre-emption rights from the other registered shareholders   of the company;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
copy of the   share certificate of 1 share of MediMarketing Inc. issued in favour of the   Buyer; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
copy evidencing   the termination of any power of attorney (or local equivalent instrument)   given on the bank accounts of MediMarketing Inc. to the Seller’s Group   representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.10
  	
  
In respect   of the Company MediMedia Pacific Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
copy of the   written resolution of MediMedia Pacific Ltd approving the transfer of 999   shares of MediMedia Pacific Ltd by the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   instrument of transfer of 999 shares of MediMedia Pacific Ltd by the Seller   to the Buyer, together with sold note;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   contract note in respect of 1,000 shares executed by the Seller;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy of the   certificates relating to the transfer of 999 shares to the Buyer;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
original/certified   copy of the declaration of trust for 1 share of MediMedia Pacific Ltd in   favour of the Buyer executed by Ng Joo Meng; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Pacific Ltd and its   Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.11
  	
  
In respect   of the Company MediMedia Asia Pte Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(a)
  	
  
copy of the   executed share transfer form for the 15,250,000 shares in MediMedia Asia Pte   Ltd;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   share certificate issued by MediMedia Asia Pte Ltd in the name of the Seller;   and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Asia Pte Ltd and its   Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.12
  	
  
In respect   of the Company MediMedia Korea Chusik Hoesa:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   share transfer agreement in the agreed form set out in schedule J.5   for the transfer of 320,000 shares of MediMedia Korea Ltd to the Buyer   executed by the Seller;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   share certificates of MediMedia Korea Chusik Hosea issued in the name of the   Seller; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediMedia Korea Chusik Hoesa and   its Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  

47

	
  
3.13
  	
  
In respect   of the Company Atmedica Malaysia Sdn Bhd:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   declaration of trust for 150,000 shares of Atmedica Malaysia Sdn Bhd in   favour of the Buyer executed by Chong Keng Tuck;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   declaration of trust for 100,000 shares of Atmedica Malaysia Sdn Bhd in   favour of the Buyer executed by Yeo Eng Peow; and
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(c)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of Atmedica Malaysia Sdn Bhd to the   Seller’s Group representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.14
  	
  
In respect   of the Company PT Infomaster:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of a   nominee arrangement for 130 shares of PT Infomaster in favour of the Buyer   executed by Veronica Cynthia Siswantoro;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   powers of attorneys of Veronica Cynthia Siswantoro in favour of the Buyer;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of a   nominee arrangement for 2,470 shares of PT Infomaster in favour of the Buyer   executed by Antonius Vidi Kamadjaja; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy of the   powers of attorney of Antonius Vidi Kamadjaja in favour of the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.15
  	
  
In respect   of the Company MediProm Malaysia Sdn Bhd:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   declaration of trust for 5,501 shares of MediProm Malaysia Sdn Bhd in favour   of the Buyer executed by Chong Keng Tuck;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   declaration of trust for 1,499 shares of MediProm Malaysia Sdn Bhd in favour   of the Buyer executed by Lee Chee Kian;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   declaration of trust for 3,000 shares of MediProm Malaysia Sdn Bhd in favour   of the Buyer executed by Chong Keng Yuen; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediProm Malaysia Sdn Bhd to the   Seller’s Group representatives, as listed in the Disclosure Letter.
  
	
  
 
  	
  
 
  	
  
 
  
	
  3.16
  	
  
In respect   of the Company MediData Pte Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   executed declaration of trust for one share of MediData Pte Ltd in favour of   the Buyer executed by Lee Chee Kian together with a blank share transfer form   signed by Lee Chee Kian and the share certificate issued in the name of Lee   Chee Kian;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
copy of the   executed declaration of trust for one share of MediData Pte Ltd in favour of   the Buyer executed by Chow Yuen Peng together with a blank share transfer   form signed by Chow Yuen Peng and the share certificate issued in the name of   Chow Yuen Pang;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copies of   executed documents revoking the trusts previously created in favour of the   Seller; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of MediData Pte Ltd and its   Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  

48

	
  
3.17
  	
  
In respect   of the Company Atmedica India Pvt Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
copy of the   Atmedica Indian Consent;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
(b)
  	
  
copy of the   board resolution of Atmedica India Pvt Ltd approving the transfer of 120   shares by the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(c)
  	
  
copy of the   share transfer deed (Form 7B) for the transfer of 120 shares of Atmedica   India Pvt Ltd by the Seller to the Buyer;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(d)
  	
  
copy of the   original share certificates;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(e)
  	
  
in   connection with the FIPB notification procedure, copy of the letter of   acceptance whereby the Seller accepts the offer letter of the Buyer; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
(f)
  	
  
copy   evidencing the termination of any power of attorney (or local equivalent   instrument) given on the bank accounts of Atmedica India Pvt Ltd and its   Subsidiaries to the Seller’s Group representatives, as listed in the   Disclosure Letter.
  

49

SCHEDULE H

LIST OF THE DOCUMENTS TO BE DELIVERED BY THE BUYER
 TO THE SELLER PURSUANT TO CLAUSE 6.3(B)

	
  
1.
  	
  
Documents to be delivered in respect of the France Shares:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   tax transfer form (formulaire cerfa n°2759   DGI)executed by the   Buyer in connection with the transfer of the France Shares to the Buyer.
  
	
   
  	
  
 
  	
  
 
  
	
  
2.
  	
  
Documents to be delivered in respect of the Spain Shares:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.1 in respect   of the transfer of the Spain Shares to the Buyer executed by the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.
  	
  
Documents to be delivered in respect of the Santémedia Shares:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.1
  	
  
In respect   of the Company MediMedia Holding Germany GmbH:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.2 in respect   of the transfer of 1 share of MediMedia Holding Germany GmbH to the Buyer   executed by the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.2
  	
  
In respect   of the Company MediMedia Netherlands BV:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.3 in respect   of the transfer of 401 shares of MediMedia Netherlands BV to the Buyer   executed by the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  3.3
  	
  
In respect   of the Company MediMedia International SP Zoo:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   notarised deed in the agreed form set out in schedule J.4 in respect   of the transfer of 100 shares of MediMedia International SP Zoo BV to the   Buyer executed by the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.4
  	
  
In respect   of the Company MediMedia Korea Chusik Hoesa:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   share transfer agreement in the agreed form set out in schedule J.5   for the transfer of 320,000 shares of MediMedia Korea Ltd to the Buyer   executed by the Buyer.
  
	
   
  	
  
 
  	
  
 
  
	
  
3.5
  	
  
In respect   of the Company MediMedia Pacific Ltd:
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   bought note executed by the Buyer in connection with the transfer of 999   shares from the Seller to the Buyer.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.6
  	
  
In respect   of the Company Atmedica India Pvt Ltd:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
copy of the   share transfer deed (Form 7B) for the transfer of 120 shares of Atmedica   India Pvt Ltd by the Seller to the Buyer executed by the Buyer;
  

50

SCHEDULE I

FORM OF THE LETTERS OF RESIGNATION

51

Mr. •
 •

	
  
 
  	
  
MediMedia   Holding Australia Pty Ltd
  
	
  
 
  	
  
•
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
For the   attention of the Members of the Board of Directors
  
	
  
 
  	
  
 
  
	
  
 
  	
  
• ___, 2004
  

Dear Sir,

I have the honour of presenting you with my resignation as director of MediMedia Holding Australia Pty Ltd as from • 2004 and thank you for taking note of this.

Further, I hereby confirm that this decision was taken of my own free will and expressly declare that, at today’s date, your company does not owe me any sum of money for any reason whatsoever.

	
  
Yours   faithfully,
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
Mr. •
  	
  
 
  

Mr. •
 •

	
   
  	
  
MediMedia   Australia Pty Ltd
  
	
  
 
  	
  
•
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
For the   attention of the Members of the Board of Directors
  
	
  
 
  	
  
 
  
	
  
 
  	
  
• ___, 2004
  

Dear Sir,

I have the honour of presenting you with my resignation as a director of MediMedia Australia Pty Ltd as from • 2004 and thank you for taking note of this.

Further, I hereby confirm that this decision was taken of my own free will and expressly declare that, at today’s date, your company does not owe me any sum of money for any reason whatsoever.

	
  Yours   faithfully,
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
Mr. •
  	
  
 
  

Mr. •
 •

	
  
 
  	
  
MediMedia   (NZ) Ltd
  
	
  
 
  	
  
•
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
   
  	
  
For the   attention of the Members of the Board of Directors
  
	
  
 
  	
  
 
  
	
  
 
  	
  
• ___, 2004
  

Dear Sir,

I have the honour of presenting you with my resignation as director of MediMedia (NZ) Ltd as from • 2004 and thank you for taking note of this.

Further, I hereby confirm that this decision was taken of my own free and expressly declare that, at today’s date, your company does not owe me any sum of money for any reason whatsoever.

	
  
Yours   faithfully,
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  Mr. •
  	
  
 
  

Mr/Mrs [insert name of the director]
 [insert address]

	
  
 
  	
  
Santémedia   Holding S.à.r.l.
  
	
  
 
  	
  
[Address]Germany
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
• 2004
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Served by hand
  

Dear Sirs,

I hereby tender to you as to you as sole shareholder and in your capacity to hold a shareholders’ meeting of MediMedia Holding Germany GmbH my resignation as a managing director of the company MediMedia Holding Germany GmbH.

This resignation takes effect [as from today/on •].

I confirm that I make this decision freely and hereby renounce any claim I may have against the company MediMedia Holding Germany GmbH or its shareholders howsoever arising.

Yours sincerely

Mr/Mrs [insert name of the director]
 [insert address]

	
  
 
  	
  
MediMedia   Holding Germany GmbH
  
	
  
 
  	
  
Am Forsthaus   Gravenbruch 5-7
  
	
  
 
  	
  
63263 Neu   Isenburg
  
	
  
 
  	
  
Germany
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
   
  	
  
• 2004
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Served by hand
  

Dear Sirs,

I hereby tender to you as sole shareholder and in your capacity to hold a shareholders’ meeting of MediMedia Medizinische Medien Informations GmbH my resignation as a managing director of the company MediMedia Medizinische Medien Informations GmbH.

This resignation takes effect [as from today/on •].

I confirm that I make this decision freely and hereby renounce any claim I may have against the company MediMedia Medizinische Medien Informations GmbH or its shareholders howsoever arising.

Yours sincerely

	
  
 
  	
  
[Date]
  
	
  
 
  	
   
 
	
  
 
  	
  
To the shareholders and the board of directors
  
	
   
  	
  
of the Belgian limited liability company
  
	
  
 
  	
  
(société anonyme/naamloze   vennootschap)
  
	
  
 
  	
  
SA/NV_________________________
  
	
  
 
  	
   
 
	
  
 
  	
  
[address of the registered office of the   Company]
  

Dear shareholders and directors,

Resignation as a director [and managing director] (“administrateur/bestuurder”)of SA/NV_______________________ (the “Company”)

I hereby tender my resignation as director of the Company as of [Date].

I confirm that I do not have any outstanding claims against the Company whatsoever for loss of office, accrued remuneration or otherwise.

I would appreciate if you would take note of my resignation and I kindly request you to take all necessary steps to publish my resignation in the Annexes to the Belgian Official Gazette and take all other actions legally required.

	
  Yours   sincerely,
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
[NAME]
  	
  
 
  

Resignation
 from Membership in the Management Board
Rezygnacja z czlonkostwa w Zarzadzie

	
  
To/Do:
  	
  
MediMedia International Sp. z o.o.
  
	
  
 
  	
  
Pl. Bankowy 2
  
	
  
 
  	
  
00-095 Warszawa
  

[...] May/maja 2004

Pursuant to Art. 202 § 4 of the
Commercial Companies Code, I hereby resign from the membership in the Management
Board of MediMedia International Sp. z o.o. with its seat in Warsaw, entered
into the register of entrepreneurs of the National Court Register under KRS No.
0000129566. My resignation shall be effective as of [...],2004.
Zgodnie z art. 202 § 4 ksh skladam niniejszym rezygnacje z funkcji
czlonka Zarzadu spólki MediMedia International Sp. z o.o. z siedziba w
Warszawie, wpisanej do rejestru przedsiebiorców Krajowego Rejestru
Sadowego za numerem KRS nr 0000129566. Moja rezygnacja jest skuteczna od dnia
[...] 2004.

	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
[...]
  	
  
 
  

	
  
To the   shareholders and
  	
  
 
  
	
  management   board of
  	
  
 
  
	
  
MediMedia   Netherlands B.V.
  	
  
 
  
	
  
Transistorstraat   44 I
  	
  
 
  
	
  
1322 CG   Almere
  	
  
 
  
	
  
The   Netherlands
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
________________,   ________________2004
  	
  
 
  

Dear Sirs,

I herewith inform you that I will resign as managing director of MediMedia Netherlands B.V. as per the moment of the execution of the notarial deed of transfers of the entire issued share capital of MediMedia Netherlands B.V. by Santémedia Holding S.à.r.l. to [  ], such deed drawn up by NautaDutilh N.V. and bearing the reference 82028312 AMS C 90838.

	
  
Yours   sincerely,
  	
  
 
  
	
  
 
  	
  
 
  
	
   
 	
  
 
  
	
  
•
  	
  
 
  

Mr. •
 •

	
  
 
  	
  
VIDAL S.A.
  
	
  
 
  	
  
•
  
	
  
 
  	
  
 
  
	
  
 
  	
  
For the   attention of the Members of the Board of Directors
  
	
   
  	
  
 
  
	
  
 
  	
  
• ___, 2004
  

Dear Sir,

I have the honour of presenting you with my resignation as director of the board of VIDAL S.A. as from • 2004 and thank you for taking note of this.

Further, I hereby confirm that this decision was taken of my own free and expressly declare that, at today’s date, your company does not owe me any sum of money for any reason whatsoever.

	
  
Yours   faithfully,
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
Mr. •
  	
  
 
  

SCHEDULE J

AGREED FORM OF TRANSFER AGREEMENTS

52

SCHEDULE J.1

THE SPAIN SHARES

53

          ESCRITURA DE COMPRA-VENTA DE ACCIONES, OTORGADA POR EDICIONES DOYMA S.L., A FAVOR DE *.________________

          NUMERO

          EN MADRID, a

          Ante mi, IGNACIO MARTÍNEZ-GIL VICH, Notario de Madrid, __________________________________________

COMPARECEN

          DE UNA PARTE: *. ____________________________

          Y DE OTRA: *. ________________________________

INTERVIENEN

          a) Don , en nombre y representación como apoderado de la sociedad Ediciones Doyma S.L., sociedad unipersonal, validamente constituida y existente, conforme a la ley española, con domicilio en Barcelona, Travessera de Gracia, números 17 y 21, e inscrita en el Registro Mercantil de Barcelona, tomo 30.604, folio 210, hoja B-175.837, con N.I.F B-61578563.

          b) Don , en nombre y representación como apoderado de la sociedad “”,

          Tienen, a mi juicio, capacidad suficiente para esta escritura de compraventa y, en su virtud, _________

EXPONEN:

          I.- Que Ediciones Doyma S.L., sociedad unipersonal, es titular de diez mil (10.000) acciones nominativas (las “Acciones”), números uno (1) a diez-mil (10.000), ambos inclusive, de Euros 6.010121 de valor nominal cada una, todas ellas totalmente desembolsadas, de la Entidad Mercantil denominada “MediMedia Medicom S.A.”, sociedad unipersonal, de nacionalidad española, domiciliada en Madrid, calle Infanta Mercedes 90, sexta planta, Madrid; constituida en escritura otorgada ante el notario de Madrid D. Juan Alvarez-Sala Walther el día 15 de julio de 1991, con el número 1893 de orden de protocolo, INSCRITA en el Registro Mercantil de Madrid, en el tomo 2093, folio 113, Hoja número M-37.146, inscripción 1a, y con C.I.F número A80106727. ___________________________________

          TITULO: La escritura pública de reducción y aumento de capital social de fecha de 28 de diciembre de 2000, otorgada ante el Notario de Barcelona D. Vicente Pons Llácer, con el número 4.716 de su protocolo, inscrita en el Registro Mercantil de Barcelona en el tomo *, folio *, Hoja número *, inscripción *. ________________________

          CARGAS: Declara el titular que dichas acciones carecen de cargas, embargos y gravámenes, y que no se han emitido títulos representativos de las Acciones. ________________________________

          II.-
Que con fecha de hoy, la entidad SANTEMEDIA HOLDING S.à r.l., constituida
con arreglo a las leyes de Luxemburgo, y con domicilio social en 5, Parc
d’Activité Syrdall, L-5365 Münsbach, Luxembourg, que es
indirectamente titular del 100% del capital de la vendedora, y la compradora han
firmado un acuerdo marco redactado en idioma inglés y sometido a derecho
francés (el “Acuerdo Marco”) donde, entre otras cosas, se
pacta la compraventa de las Acciones y los términos y condiciones de la
misma.

          III.- Que no existe limitación estatutaria a la transmisibilidad de las Acciones.

          IV.- Que, en ejecución del Acuerdo Marco, la Vendedora y la Compradora desean solemnizar la transmisión de las Acciones con arreglo a las siguientes __________________________________________

CLAUSULAS:

          PRIMERA: Ediciones Doyma S.L., sociedad unipersonal, vende a , que compra, el pleno dominio de las Acciones antes relacionadas. ____________

          SEGUNDA: El precio global por las Acciones es el de, que la compradora entrega a la vendedora en este acto mediante cheque bancario nominativo, del que se adjunta copia a esta escritura como Anexo II, otorgando la compradora carta de pago por la referida cantidad salvo buen fin. ______________

          TERCERA: Los gastos e impuestos de esta escritura, incluyendo, en particular, los honorarios y costes notariales, serán a cargo de la compradora.

          : De conformidad con lo dispuesto por el artículo 45.I.B del Texto Refundido de la Ley del Impuesto sobre Transmisiones Patrimoniales y Actos Jurídicos Documentados (Real Decreto Legislative 1/1993 de 24 de septiembre por el que se aprueba el referido Texto Refundido), la presente operación esta exenta de tributación, por no darse ninguno de los casos de excepcióncontemplados en ese artículo.

          QUINTA: Las partes reconocen y aceptan que presente transmisión se realiza en ejecución del Acuerdo Marco, del que trae causa y sin que la presente escritura constituya modificación alguna de aquél, quedando los términos y condiciones del contrato de compraventa íntegramente supeditados y sometidos al régimen contenido en ese Acuerdo Marco, incluyendo, en particular, la ley y jurisdicción aplicables al contrato. ______________________________________

          Hechas las reservas y advertencias legales.___________

          Doy cumplimiento al requisito de la lectura, conforme a lo determinado en el artículo 193 del Reglamento Notarial, y los otorgantes encuentran conforme la presente escritura, se ratifican y firman. ____________________________________

          Y yo, el Notarío, doy fe de conocer a los comparecientes y de lo consignado en este instrumento público, extendido en folios de clase notarial, números

          PUBLIC DEED OF SALE AND PURCHASE OF SHARES GRANTED BY EDICIONES DOYMA, S.L., IN FAVOUR OF * --

          NUMBER

          IN MADRID, on

          Before me, IGNACIO MARTINEZ-GIL VICH, Notary of Madrid, _____________________

PRESENT

          ON THE ONE PART: *. ______________________________________

          ON THE OTHER PART: *. _____________________________________

THEY APPEAR

          a) Mr , in the name and on behalf, as attorney, of the company Ediciones Doyma S.L., sole shareholder company, validly incorporated and existing in accordance with Spanish law, with domicile in Barcelona, Travessera de Gracia, numbers 17 and 21, and registered with the Barcelona Commercial Registry, tomo 30.604, folio 210, hoja B-175.837, with Tax Identification Number B-61578563.

          b) Mr. , in the name and on behalf, as attorney, of the company “”,

          I judge that the appearers have sufficient capacity for the granting of this deed of transfer

WHEREAS :

          I.- Ediciones Doyma S.L.,sole shareholder company, is the owner of ten thousand. (10,000) nominative shares (the “Shares”), numbers one (1) to ten thousand (10,000), both inclusive, of a nominal value of Euro 6.010121 each, all of which are fully paid up, of the company “MediMedia Medicom S.A.”, sole shareholder company, of Spanish nationality, with domicile in Madrid, Infanta Mercedes 90, sixth floor; incorporated by virtue of public deed granted before the Madrid Notary public Mr. Juan Alvarez-Sala Walther on 15 July 1991, with number 1893 of his notarial records, REGISTERED with the Madrid Commercial Registry, tomo 2093, folio 113, Hoja M-37.146, first entry, and with Tax Identification Number A80106727. _______________

          TITLE: The public deed of decrease and increase of share capital dated 28 December 2000, granted before the Barcelona Notary Public Mr. Vicente Pons Llácer, under number 4716 of his notarial records, registered with the Barcelona Commercial Registry, tomo *, folio *, Hoja *, * entry. ______________

          CHARGES: The owner declares that such shares are free from any charges, encumbrances and attachments, and that there are no share certificates issued. __________________________

          II.- On the date hereof, the company SANTEMEDIA HOLDING S.à r.l., incorporated in accordance with the laws of Luxembourg, and with corporate domicile at 5, Parc d’Activité Syrdall, L-5365 Münsbach, Luxembourg, who is the indirect owner of 100% of the capital of the seller, and the buyer have executed a framework agreement drafted in the English language and subject to French law (the “Framework Agreement”) whereby, among others, the parties agree the sale and purchase of the Shares and the terms and conditions thereof.

          III.- That there are no restrictions to the transfer of the Shares set out in the by-laws of the company.

          IV.- That, in performance of the Framework Agreement, the seller and the buyer wish to formalise the transfer of the Shares in accordance with the following _____________________________

CLAUSES:

          FIRST: Ediciones Doyma S.L., sole shareholder company, sells to , who purchases, full ownership over the Shares above mentioned. _______________

          SECOND: The aggregate price for the Shares is of , that the buyer delivers to the seller in this act by means of a nominative banking cheque a copy of which is attached as Schedule II. The buyer acknowledges receipt of such amount. _____________

          THIRD: Any taxes and expenses arising from this deed, including, without limitation, the notarial fees and charges, shall be borne by the buyer.

          : In accordance with what is provided for under article 45.I. of the Consolidated Text of the Law on Transfer Tax and Stamp Duty (Royal Legislative Decree 1/1993 of 24 September, approving the referred. Consolidated Text) , this transaction is exempt from taxation because none of the exceptions contemplated in such article concur.

          FIFTH: The parties acknowledge and agree that the present transfer is made in performance of the Framework Contract, that is the cause of this transaction, and that this public deed does not amend such Framework Agreement but that the terms and conditions of the sale and purchase are fully subject to the Framework Agreement including, in-particular, the applicable law and jurisdiction of the agreement.

[FORMAL CLOSURE OF THE DEED]

SCHEDULE J.2

MEDIMEDIA HOLDING GERMANY GmbH

54

SHARE TRANSFER AGREEMENT

BETWEEN

Santemedia Holding S.a.r.l., a société à responsabilité. limitée organised under the laws of the Grand Duchy of Luxembourg, having its registered office at 5, Parc d’Activité Syrdall, L-5365 Münsbach,. Luxembourg, (“Transferor”)

and

[insert name of buyer](“Transferee”)

PREAMBLE:

	
  1.
  	
  
By share   purchase agreement dated • 2004 entered into between, the Transferor and the   Transferee (the “Share Purchase Agreement”),   the Transferor and the Transferee agreed on the sale of the share held by the   Transferor in MediMedia Holding Germany GmbH (the “Company”).
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
The Transferor   is the sole shareholder of the Company. The Company is registered in the   Commercial Register of the local court (Amtsgericht)   of Offenbach am Main under HRB 40052. The registered share capital   of EUR 25,000.00 and is divided into one share in the nominal amount of EUR   25,000.00 (the “Share”).
  
	
  
 
  	
  
 
  
	
  
1.
  	
  
SHARE TRANSFER
  
	
  
 
  	
  
 
  
	
  
1.1
  	
  
The   Transferor hereby transfers to the Transferee the Share. The Transferee   accepts such transfer.
  
	
  
 
  	
  
 
  
	
  1.2
  	
  
The share   transfer is effected pursuant to the Share Purchase Agreement.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
CONDITION PRECEDENT
  
	
  
 
  	
  
 
  
	
  
 
  	
  
This   agreement is subject to the - condition precedent (aufschiebende Bedingung) that completion under the Share   Purchase Agreement will occur. As proof of the satisfaction of such condition   precedent, it shall be sufficient if the acting notary receives a letter   materially in the form attached to this agreement as an exhibit signed by the   seller and/or buyer confirming that completion has occurred.
  
	
  
 
  	
  
 
  
	
  
3.
  	
  
FINAL PROVISIONS
  
	
  
 
  	
  
 
  
	
  
3.1
  	
  
This   agreement shall be governed by the laws of Germany.
  
	
   
  	
  
 
  
	
  
3.2
  	
  
The cost of   this notarial deed shall be bom by the Transferee.
  
	
  
 
  	
  
 
  
	
  
3.3
  	
  
The Company   does not own real property.
  
	
  
 
  	
  
 
  
	
  
3.4
  	
  
The notary   is hereby instructed not to provide the Transferor and the Transferee with a   notarised copy of this notarial deed before he has received the confirmation   letter in accordance with clause 2 above.
  

Further, the notary is hereby instructed to notify the Company about the transfer of the shares transferred under this agreement according to § 16 GmbHG.

The notary advised the persons appearing

	
  
 
  	
  
-
  	
  
that,   pursuant to section 16 GmbHG, as towards the Company only the party whose   acquisition was notified to the Company, furnishing evidence of the transfer,   is deemed to be the purchaser in the event of a disposal of a share and that,   in addition to the seller, the purchaser is liable for the payments in   arrears on the share as at the time of registration; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
that the   managing director of the company is obliged to submit and complete list of   shareholders immediately following the occurrence of any chances of the   person of a shareholder or in the amount of this participation.
  

The foregoing record was read by the notary to the persons appearing, approved by them and signed by the person appearing and the notary:

EXHIBIT

	
  
To:
  	
  
Notar
  
	
  
 
  	
  
[insert name and address of the notary]
  
	
  
 
  	
  
Germany
  
	
  
 
  	
  
Fax: [insert fax number]
  

We hereby confirm that completion of the sale and purchase of the shares in MediMedia Holding Germany GmbH pursuant to the Sale and Purchase Agreement dated • 2004, has occurred on • 2004.

	
  
[insert   place], • 2004
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
Santemedia   Holding S.a.r.l.
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  

  	
  
 
  
	
  
MediMedia   Holding Germany GmbH
  	
  
 
  

SCHEDULE J.3

MEDIMEDIA NETHERLANDS BV

55

	
  
 
  	
  
1
  
	
  
 
  	
  
NautaDutilh   N.V.
  

DEED OF TRANSFER OF SHARES
 MEDIMEDIA NETHERLANDS B.V.

On this, the [ ] day of [ ] two thousand and four, came and appeared before me, Wijnand Hendrik Bossenbroek, civil law notary in Amsterdam:

	
  
1.
  	
  
[ ],
  
	
  
 
  	
  
acting for   the purposes hereof as attorney - duly authorized in writing - of
  
	
  
 
  	
  
Santémedia   Holding S.à.r.l. a company incorporated under the   laws of the Grand Duchy of Luxembourg, having its registered office at 5,   Parc d’Actinité Syrdal, L-5365, Münsbach, Luxembourg, Grand Duchy of Luxembourg,   the principal being hereinafter referred to as: the “Vendor”;
  
	
  2.
  	
  
[ ],
  
	
  
 
  	
  
acting for   the purposes hereof as attorney - duly authorized in writing - of [ ], the   principal being hereinafter referred to as: the “Purchaser”; and
  
	
  
3.
  	
  
[ ],
  
	
  
 
  	
  
acting for   the purposes hereof as attorney - duly authorized in writing - of MediMedia   Netherlands B.V., a private company with limited liability incorporated   under the laws of the Netherlands, having its corporate seat in Naarden   (address: 1322 CG Almere, Transistorstraat 44I, trade register number:   27141858), the principal being hereinafter referred to as: the “Company”.
  

The persons appearing sub 1. and sub 2. declared as follows:

PURCHASE AGREEMENT
 Article 1.

By written share purchase agreement dated the [ ] day of [ ] two thousand and four - hereinafter referred to as: the “Purchase Agreement” - the Vendor sold to the Purchaser and the Purchaser purchased from the Vendor the shares in the share capital of the Company hereinafter described.

The provisions of the Purchase Agreement which are still applicable at this time shall remain in force insofar as not inconsistent with this deed.

THE SHARES
 Article 2.

The Purchase Agreement concerns four hundred and one (401) ordinary shares in the share capital of the Company, each share having a nominal value recorded in the Company’s articles of association of one hundred Dutch guilders (NLG 100), numbered 1 up to and including 401, hereinafter referred to as: the “Shares”.

	
  
 
  	
  
2
  
	
  
 
  	
  
NautaDutilh   N.V.
  

MANNER OF ACQUISITION OF THE SHARES BY THE VENDOR
 Article 3.

The Shares were transferred to the Vendor, pursuant to a purchase agreement, by a deed of transfer executed before a deputy of Frank Robert Sterel, civil law notary in Amsterdam, on the twenty-seventh day of June two thousand and two. 

The transfer was acknowledged by the Company on the same day as is evidenced by that same notarial deed.

PAYMENT OF THE PURCHASE PRICE
 Article 4.

The purchase price for the Shares is set forth in the Purchase Agreement and shall be settled in accordance with the applicable provisions of the Purchase Agreement.

SHARE TRANSFER RESTRICTIONS
 Article 5.

In its capacity as sole shareholder of the Company, the Vendor hereby resolves (pursuant to article 23 of the Company’s articles of association) to approve the present transfer of the Shares, thus observing the share transfer restrictions in the Company’s articles of association. The members of the Company’s board of management have had the opportunity to render advice as to the above resolution. 

TRANSFER
 Article 6.

Pursuant to the Purchase Agreement, the Vendor hereby transfers the Shares to the Purchaser who accepts this transfer.

WARRANTIES
 Article 7.

The Vendor warrants to the Purchaser that:

	
  
a.
  	
  
it has full   power and authority to transfer the Shares to the Purchaser;
  
	
  
b.
  	
  
there are no   options or other rights entitling the holder thereof to the transfer of any   of the Shares;
  
	
  
c.
  	
  
the Shares   are free of any and all encumbrances, pledges, rights of usufruct or other   rights, and no encumbrance, pledge, vesting of a right of usufruct or other   right can be demanded in respect of the Shares, nor has any attachment been   levied on any of the Shares; [the Shares are currently encumbered with a   right of pledge, which needs to be released prior to the execution of this   deed]
  

BENEFITS AND BURDENS
 Article 8.

All benefits and burdens of the Shares shall, as from [the date hereof][the [ ] day of [ ] two thousand and [ ]], accrue to or, as the case may be, be borne by the Purchaser.

COSTS
 Article 9.

The costs incidental to this deed, including, without limitation, the notarial fees and charges, and the execution thereof shall be borne by the Purchaser.

	
   
  	
  
 
  
	
  
 
  	
  
3
  
	
  
 
  	
  
NautaDutilh   N.V.
  

CONDITIONS. RESCISSION
 Article 10.

	
  
1.
  	
  
All   conditions subsequent (in Dutch: “ontbindende voorwaarden”) which have been   agreed upon in the Purchase Agreement or in supplemental agreements relating   to the purchase have now lapsed and are hereby rendered entirely devoid of   legal effect.
  
	
  
 
  	
  
 
  
	
  
 
  	
  
All   conditions precedent (in Dutch: “opschortende voorwaarden”) which have been   agreed upon in the Purchase Agreement or in supplemental agreements relating   to the purchase have now been fulfilled or waived and are hereby rendered   entirely devoid of legal effects.
   Neither the Vendor nor the Purchaser may any longer claim the benefit of any   condition subsequent or condition precedent in respect of this purchase and   transfer.
  
	
   
  	
  
 
  
	
  
2.
  	
  
The parties   hereto expressly waive their right to demand the rescission of the Purchase   Agreement and the other agreements incidental to the transfer of the Shares.
  

ACKNOWLEDGEMENT
 Article 11.

The Company declares that it has taken cognizance of and hereby acknowledges the transfer of the Shares.

The Company shall immediately enter this transfer in its shareholders’ register. The Company declares that it has at all times and without interruption accepted as valid all transfers of the Shares preceding the present transfer.

[ARTICLE  [2:204C][2:94C] OF THE DUTCH CIVIL CODE
 Article 12.

The persons appearing further declared that the provisions laid down in article 2:204c of the (Dutch) Civil Code are not applicable to this transfer to the Purchaser.]

CIVIL LAW NOTARY
 Article 13.

The parties to this deed are aware that the undersigned civil law notary works with NautaDutilh N.V., the firm that has advised the Vendor in this transaction. With reference to the Code of Conduct (Verordening beroeps-en gedragsregels) established by the Royal Notarial Professional Organisation (Koninklijke Notariële Beroepsorganisatie), the parties hereby explicitly consent to (i) the undersigned civil law notary executing this notarial deed and (ii) the Vendor being assisted and represented by NautaDutilh N.V. in relation to this deed and any agreements that may be concluded, or disputes that may arise, in connection herewith.

AUTHORITY AND POWERS OF ATTORNEY
 Article 14.

The persons appearing have been granted power of attorney by means of three (3) non-notarial instruments of attorney, which will be attached to this deed.

FINAL PART

The persons appearing are known to me, civil law notary.

This deed was executed in Amsterdam on the date mentioned in its heading.

	
  
 
  	
  
4
  
	
  
 
  	
  
NautaDutilh   N.V.
  

After I, civil law notary, had conveyed and explained the contents of the deed in substance to the persons appearing, they declared that they had taken note of the contents of the deed, were in agreement with its contents and did not wish them to be read out in full.

Following a partial reading, the deed was signed by the persons appearing and me, civil law notary.

SCHEDULE J.4

MEDIMEDIA INTERNATIONAL SP ZOO

56

Agreement on Sale of Shares

This agreement on sale of shares (the “Agreement”) was made on [...], 2004. in [...] by and between:

	
  
1
  	
  
Santemedia Holding S.a.r.l, a company   incorporated under the laws of Luxemburg, with its registered seat at 5. Parc   d’Activité Syrdaff, L-5365 Münsbach, Luxemburg, represented by [...], (the “Seller”);
  
	
  
 
  	
  
 
  
	
  
and
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
[...], a company organized and existing under   the laws of [...], with its registered office at [...], represented by [...]   (the “Buyer”);
  

WHEREAS, the Seller is the holder of 100 shares of the aggregate par value of 50,000 (Fifty Thousand) zloty (the “Shares”) constituting 100% of the share capital of MediMedia International Sp. z o.o. (the “Company”), a Polish limited liability company with its registered seat in Warszawa at Plac Bankowy 2, entered into the National Court Register under number 0000129566;

WHEREAS, on [...] 2004, the Seller and the Buyer signed [...]agreement pursuant to which the Seller should sell the Shares to the Buyer;

WHEREAS, the Buyer wishes to purchase the Shares from the Seller; 

the parties hereto (the “Parties”) agree as follows:

Article 1
 Sale of Shares

	
  
1.
  	
  
The Seller   hereby sells to the Buyer and the Buyer hereby buys from the Seller all 50   (Fifty) Shares against payment of price specified in Article 2 below.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
For the   avoidance of doubt the title to the Shares passes from the Seller to the   Buyer [by virtue hereof and on the date hereof/ on the date of payment of the   price].
  

Article 2
 Price

	
  
1.
  	
  
In   consideration for the transfer of Shares on the basis hereof the Buyer shall   pay to the Seller the price in the amount of [...]   Euro ([...]) Euro.
  
	
   
  	
  
 
  
	
  
2.
  	
  
The price   shall be paid by the Buyer on the day hereof, by bank transfer to the   Seller’s bank account.
  

Article 3
 Notifications

According to Art. 187 of the Commercial Companies Code the Buyer shall notify the Company about the transfer of the Shares from the Seller to the Buyer within [3] days as from the date hereof.

Article 4
 Representations and Warranties

The Seller and the Buyer hereby represent and warrant to the other party that as at the date of this Agreement:

	
  
1.
  	
  
The Seller   and the Buyer have full power and authority to enter into this Agreement and   to carry out their obligations hereunder.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
The   execution of, and the obligation to perform, this Agreement by the Seller and   the Buyer and the obligation of execution by the Seller and the Buyer of all   documents required pursuant to this Agreement are valid, binding and legally   enforceable against the Seller and the Buyer.
  
	
   
  	
  
 
  
	
  
3.
  	
  
Neither the   execution of this Agreement, nor the completion of the transactions   contemplated in this Agreement, results or will result in a violation of (i)   any law or other regulation binding or applicable to the Seller and the   Buyer, and/or (ii) any court decisions or decisions issued by any   governmental bodies to which the Seller and the Buyer are subject.
  

Article 5
 Final Provisions

	
  
1.
  	
  
This   Agreement is executed in writing in two identical copies in English and in   Polish with signatures certified by the notary. In case of discrepancies   between the language versions, the Polish language version shall prevail.
  
	
  
 
  	
  
 
  
	
  
2.
  	
  
Except as   otherwise expressly stated hereinabove, each Party shall bear its own costs   (including attorneys’ and other consultants’ fees) incurred in connection   with negotiations., execution and performance hereof. The due tax on civil   law transactions, as well as all notarial fees and cost related hereto, shall   be paid by the Buyer. The Buyer shall present to the Seller a proof of   payment of the foregoing tax within 7 days   of the date hereof.
  
	
   
  	
  
 
  
	
  
3.
  	
  
Any   modification hereof or amendment hereto shall be null and void unless made in   writing with signatures certified by a notary.
  
	
  
 
  	
  
 
  
	
  
4.
  	
  
This   Agreement shall be governed by and interpreted in accordance with the laws of   Poland.
  
	
  
 
  	
  
 
  
	
  
5.
  	
  
The Parties   agree that if any part of this Agreement is declared invalid or otherwise legally   defective, the remaining parts thereof shall remain in force.
  

	
  
Seller:
  	
  
 
  	
  
Buyer:
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  

  	
  
 
  	
  

  
	
  
[...]
  	
  
 
  	
  
[...]
  

SCHEDULE J.5

MEDIMEDIA KOREA CHUSIK HOSEA

57

SHARE TRANSFER AGREEMENT

THIS SHARE TRANSFER AGREEMENT (this “Agreement”) is made on the ______ day of ______ 2004
 By and between:

[1]     Santemedia Holding Sarl, a company incorporated under the laws of LUXEMBOURG with its place of business at 5, Parc d’Activité Syrdal, L-5365 LUXEMBOURG (hereinafter called the “Seller”); and

[2]     _____________________________ , a company incorporated under the laws of __________ with its place of business at _____________________________ (hereinafter called the “Buyer”).

	
  
 
  	
  
WHEREAS:
  
	
  
 
  	
  
 
  
	
  
1. 
  	
  
The Seller   holds 320,000 shares of MediMedia Korea Ltd., a company incorporated under   the laws of the Republic of Korea (“Korea”) with its place of business at BMS   Bldg., 829-1 Yeoksam-dong, Gangnam-gu, Seoul, Korea (hereinafter called the   “Company”), which is 100% of the total issued and outstanding shares of the   Company (capitalization of 1.6 billion KRW / 5,000 KRW per share).
  
	
  
 
  	
  
 
  
	
  
 
  	
  
NOW IT IS HEREBY AGREED as follows:
  
	
  
 
  	
  
 
  
	
  
1.
  	
  
DEFINITIONS AND INTERPRETATION
  
	
   
  	
  
 
  
	
  
1.1
  	
  
In this   Agreement, the following words and expressions shall have the following   meanings:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
(a)
  	
  
“Target”   means 320,000 shares of the Company held by the Seller, which is100% of the   total issued and outstanding shares of the Company.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
(b)
  	
  
“KRW” means   Korean Won, the lawful currency of Korea.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
2.
  	
  
AGREEMENT TO SELL AND BUY
  
	
   
  	
  
 
  
	
  
2.1
  	
  
Subject to   the terms and conditions of this Agreement, the Seller shall sell to the   Buyer, and the Buyer shall buy from the Seller, the Target on _____  _____, 2004.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.
  	
  
CONSIDERATION
  
	
  
 
  	
  
 
  
	
  
3.1
  	
  
The   consideration for the sale of the Target shall be __________ (the “Purchase   Price”).
  

	
  
4.
  	
  
AUTHORIZATION
  
	
  
 
  	
  
 
  
	
  4.1
  	
  
The Buyer   and the Seller hereby warrant and represent that they have power to enter   into this Agreement and to exercise their rights and to perform the   obligations expressed to be assumed by them herein and have taken all   necessary corporate action to authorise the execution, delivery and   performance of this Agreement.
  
	
  
 
  	
  
 
  
	
  
5.
  	
  
ASSIGNMENT
  
	
  
 
  	
  
 
  
	
  
5.1 
  	
  
Neither   party may assign their rights and interest under this Agreement without the   prior written consent of the other party.
  
	
  
 
  	
  
 
  
	
  
6.
  	
  
COSTS
  
	
  
 
  	
  
 
  
	
  
6.1 
  	
  
The Seller   and the Buyer shall each pay its own legal costs and expenses incurred in   connection with the preparation of this Agreement and the transactions   contemplated hereby.
  
	
   
  	
  
 
  
	
  
7.
  	
  
MISCELLANEOUS
  
	
  
 
  	
  
 
  
	
  
7.1
  	
  
This   Agreement shall continue in full force and effect notwithstanding the payment   of any moneys.
  
	
  
 
  	
  
 
  
	
  
7.2
  	
  
No amendment   to this Agreement shall be effective unless in writing and signed by the   parties.
  
	
  
 
  	
  
 
  
	
  
7.3
  	
  
The   construction validity and performance of this Agreement shall be governed in   all respects by the laws of Korea.
  
	
  
 
  	
  
 
  
	
  
7.4
  	
  
All dispute   arising out of or in connection with this Agreement shall be submitted to the   exclusive jurisdiction of the Seoul District Court.
  

                 AS WITNESS the hands of the parties hereto of their duly authorized representatives the day and year first above written.

	
  
Santemedia Holding Sarl
  	
  
 
  	
  
[Name of Buyer]
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
By:
  	
  
 
  	
  
 
  	
  
By:
  	
  
 
  
	
   
  	
  

  	
  
 
  	
  
 
  	
  

  
	
  
Name:
  	
  
 
  	
  
 
  	
  
Name:
  	
  
 
  
	
  
Title:
  	
  
 
  	
  
 
  	
  
Title:
  	
  
 
  

SCHEDULE K

ACTIONS TO BE PERFORMED BY THE SELLER
 PRIOR TO THE COMPLETION DATE

	
  
1.
  	
  
FRANCE
  
	
   
  	
  
 
  
	
  
 
  	
  
-
  	
  
Sale by   Vidal SA to a member of the Seller’s Group of its business as a going concern   “Décision Santé”.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Sale by   Vidal SA to a member of the Seller’s Group of its entire shareholding (being,   60 per cent.) of the company MediMedia Pro SAS, a société par actions simplifiée organised under the laws of   France, such transfer to be effective before 30 June 2004.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Sale by   Vidal SA to a member of the Seller’s Group of its entire shareholding (being,   100 per cent.) of OVP Italia Spa., a limited company organised under the laws   of Italy.
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Transfer by   a member of the Seller’s Group to a member of the Buyer’s Group or a Group   Company of the employment contract entered into between Mr Vincent Bouvier   and MediMedia Support EURL, or as the case may be, execution of a new   employment contract (in terms substantially identical to those of the   employment contract entered between Mr Vincent Bouvier and MediMedia Support   EURL) between Mr Vincent Bouvier and a member of the Buyer’s Group or a Group   Company.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
2.
  	
  
AUSTRALIA
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Sale by   MediMedia Australia Pty Ltd to a member of the Seller’s Group of its entire   equity interest (being, 11.2 per cent) in Health Communication Network Ltd, a   limited public company organised under the laws of Australia.
  

58

SCHEDULE L

INTRA-GROUP AGREEMENTS

NB: this list does not refer to the insurance policies entered into by the Seller’s Group and covering some members of the Group. As provided under clause 9 of the Agreement, those Insurance Policies will be terminated at Completion Date.

	
  
1.
  	
  
France
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between Vidal SA and MediMedia Support dated 14   December 2001.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service Agreement   entered into between MMHF and Vidal SA dated 7 and 11 April 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Cash pooling   agreement (convention d’omnium en mode   indirect)entered   into between, inter alia, Crédit   Commercial de France, MediMedia Support EURL and Vidal SA dated 18 December   2000 (as amended on 28 June 2002).
  
	
  
 
  	
  
 
  	
  
 
  
	
  
2.
  	
  
Spain
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between MMHF and MediMedia Medicom SA dated 30 October   2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Intercompany   Loan Agreement entered into between MediMedia Holding Spain as lender and   MediMedia Medicom as borrower dated 28 June 2002.
  
	
   
  	
  
 
  	
  
 
  
	
  
3.
  	
  
Portugal
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between MMHF and Ediçoes Simposium LDA dated 30   October 2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Intercompany   Loan Agreement entered into between Ediçoes Simposium LDA as lender and Santémedia   Finance S.à r.l as borrower dated 28 June 2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  4.
  	
  
Belgium
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   agreement entered into between MMHF and MediMedia Belgium SA dated 14 April   and 13 May 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between MMHF and MediBridge SA dated 14 April and 13   May 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Intercompany   Loan Agreement entered into between Santémedia Finance S.à r.l as lender and   MediMedia Belgium SA as borrower dated 28 June 2002.
  
	
   
  	
  
 
  	
  
 
  
	
  
5.
  	
  
The Netherlands
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   agreement entered into between MMHF and MediMedia Netherlands BV dated 14   April and 13 May 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
6.
  	
  
Germany
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   agreement entered into between MMHF and MediMedia Medizinische Medien   Information GmbH dated 13 May 2003.
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Intercompany   Loan Agreement between Santémedia Finance S.à r.l. as lender and MediMedia   Holding Germany GmbH as borrower dated 28 June 2002.
  
				

59

	
  
7.
  	
  
Hungary
  
	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between MMHF and MediMedia Information KFT dated 30   May 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
  8.
  	
  
Poland
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   agreement entered into between MMHF and MediMedia International SP ZOO dated   June 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
9.
  	
  
Australia
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   agreement entered into between MMHF and MediMedia Australia Pty Ltd dated 7   April 2003.
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Intercompany   Loan Agreement entered into between Santémedia Finance S.à r.l. as lender and   MediMedia Holding Australia Pty Ltd as borrower dated 28 June 2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
10.
  	
  
New Zealand
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Intercompany   Loan Agreement entered into between Santémedia Finance S.à r.l. as lender and   MediMedia (NZ) Ltd as borrower dated 28 June 2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
11.
  	
  
Korea
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Intercompany   Loan Agreement entered into between Santémedia Finance S.à r.l. as lender and   MediMedia Korea Chusik Hoesa as borrower dated 28 June 2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
12.
  	
  
Hong Kong
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Two   Intercompany Loan Agreements entered into between MediMedia Pacific Ltd as   lender and Santémedia Finance S.à r.l. as borrower dated 31 December 2002.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between MMHF and MediMedia Pacific Ltd dated 7 April   2003.
  
	
   
  	
  
 
  	
  
 
  
	
  
13.
  	
  
Singapore
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Service   Agreement entered into between MMHF and MediMedia Asia Pte Ltd dated 4 April   2003.
  

60

SCHEDULE M

SECURITY DOCUMENTS

	
  
1.
  	
  
AUSTRALIA
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Equitable   Mortgage of Shares dated 28 June 2002 between (1) Santémedia Holding S.à r.l.   as Mortgagor and (2) UBS (Luxembourg) S.A. as Mortgagee (& Share   Certificates and blank Stock Transfer Form);
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Equitable   Mortgage of Shares dated 28 June 2002 between (1) MediMedia Holding Australia   Pty Limited as Mortgagor and (2) UBS (Luxembourg) S.A. as Mortgagee (&   blank Stock Transfer Form);
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Fixed and   Floating Charge (All Assets and Undertaking) dated 28 June 2002 between (1)   MediMedia Holding Australia Pty Limited as Chargor and (2) UBS (Luxembourg)   S.A. as Chargee (& Certificate of Entry of a Charge);
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Fixed and   Floating Charge (Present Assets and Undertaking) dated 17 September 2002   between (1) MediMedia Australia Pty Limited as Chargor and (2) UBS   (Luxembourg) S.A. as Chargee;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Fixed and   Floating Charge (Future Assets and Undertaking) dated 17 September 2002   between (1) MediMedia Australia Pty Limited as Chargor and (2) UBS   (Luxembourg) S.A. as Chargee;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Guarantee   dated 28 June 2002 between (1) MediMedia Holding Australia Pty Limited as   Guarantor and (2) UBS (Luxembourg) S.A. as Security Agent; and
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Guarantee   dated 17 September 2002 between (1) MediMedia Australia Pty Limited as   Guarantor and (2) UBS (Luxembourg) S.A. as Security Agent.
  
	
   
  	
  
 
  	
  
 
  
	
  
2.
  	
  
FRANCE
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Statement of   Financial Instruments Account Pledge (Déclaration   de gage de compte d’instruments financiers)dated 28 June 2002 by MediMedia Holding   France S.A.S. relating to the pledge of the financial instruments account of   MediMedia Holding France S.A.S. in Vidal S.A.;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Confirmation   of Pledge (Attestation de nantissement de   compte d’instruments financiers) dated 28 June 2002 by Vidal S.A.   relating to the pledge of the financial instruments account of Médimedia   Holding France S.A.S. in Vidal S.A.;
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Financial Instruments   Accounts Pledge Agreement (Convention de   nantissement de comptes d’instruments financiers) dated 28 June   2002 between (1) MediMedia Holding France S.A.S. as Pledger and (2) UBS   (Luxembourg) S.A. as Security Agent with respect to the financial instruments   account of MediMedia Holding France S.A.S. in Masson S.A., Fonciére et   Immobilière des Hauts de Seine S.A., Vidal S.A. and MediMedia France S.A.;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Delegation   Agreement (Acte de délégation) dated   28 June 2002 between (1) Santémedia Group Holding S.à r.l., Santémedia   Finance S.à r.l., Santémedia Holding S.à r.l., Médimedia Holding France   S.A.S., MediMedia Holding Germany GmbH, Tabur 2002, S.L., MediMedia Holding   Australia Pty Limited and MediMedia Holding USA Inc. as Délégants, (2)   Vivendi Universal S.A., Vivendi Universal Publishing S.A. and Vivendi   Universal Information S.A. as Délégués and (3) UBS (Luxembourg) S.A. as   Security Agent and the other Finance Parties as Délégataires.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
3.
  	
  
GERMANY
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Share Pledge   Agreement dated 28 June 2002 between (1) Santémedia Holding S.à r.l. as   Pledgor and (2) UBS (Luxembourg) S.A. as Pledgee;
  

61

	
  
 
  	
  
-
  	
  
Share Pledge   Agreement dated 28 June 2002 between (1) MediMedia Holding Germany GmbH as   Pledgor and (2) UBS (Luxembourg) S.A. as Pledgee;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Account   Pledge Agreement (Kontoverpfãndung) dated   28 June 2002 among (1) MediMedia Holding Germany GmbH as Pledgor and (2) UBS   (Luxembourg) S.A, and others as Pledgees;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Account   Pledge Agreement (Kontoverpfändung) dated   28 June 2002 among (1) MediMedia Medizinische Medien Informations GmbH as   Pledgor and (2) UBS (Luxembourg) S.A. and others as Pledgees;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Agreement on   the Assignment of Inter-Company Loans (Abtretungsvertrag)   dated 28 June 2002 between MediMedia Holding GmbH as Assignor and   (2) UBS (Luxembourg) S.A. as Security Agent;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Agreement on   the Assignment of Inter-Company Loans (Abtretungsvertrag)   dated 28 June 2002 between MediMedia Medizinische Medien   Informations GmbH as Assignor and (2) UBS (Luxembourg) S.A. as Security   Agent;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Security   Assignment Agreement (Abtretungsvertrag) dated   11 July 2002 between (1) MediMedia Medizinische Medien Informations GmbH as   Assignor and (2) UBS (Luxembourg) S.A. as Security Agent;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Pledge   Agreement of Intellectual Property Rights dated 28 June 2002 among (1)   MediMedia Medizinische Medien Informations GmbH as Pledgor and (2) UBS   (Luxembourg) S.A. and others as Pledgees;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Guarantee   dated 28 June 2002 from MediMedia Holding GmbH to UBS (Luxembourg) S.A. as   Security Agent; and
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
-
  	
  
Guarantee   dated 28 June 2002 from MediMedia Medizinische Medien Informations GmbH to   UBS (Luxembourg) S.A. as Security Agent.
  
	
  
 
  	
  
 
  	
  
 
  
	
  
4.
  	
  
SINGAPORE
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Charge over   Shares dated 28 June 2002 by (1) Santémedia Holding S.à r.l. as Chargor in   favour of (2) UBS (Luxembourg) S.A. as Security Agent;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Debenture   dated 20 August 2002 between (1) MediMedia Asia Pte Ltd and (2) UBS   (Luxembourg) S.A. as Security Agent; and
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Guarantee   dated 20 August 2002 between (1) MediMedia Asia Pte Ltd as Guarantor and (2)   UBS (Luxembourg) S.A. as Security Agent.
  

62

	
  
5.
  	
  
THE NETHERLANDS
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Deed of   Pledge of Shares in MediMedia Netherlands B.V. dated 28 June 2002 by Santémedia   Holding S.à r.l. in favour of UBS (Luxembourg) S.A. ;
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Deed of   Release of Pledge dated 3 July 2002 in respect of shares pledged in the share   capital of MediMedia Netherlands B.V. by Santémedia Holding S.à r.l. in   favour of UBS (Luxembourg) S.A.;
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
-
  	
  
Deed of   Pledge of Shares in MediMedia Netherlands B.V. dated 3 July 2002 by   Santémedia Holding S.à r.l. in favour of UBS (Luxembourg) S.A..
  

63

SCHEDULE N

RETAINED TRADEMARKS

	
  
-
  	
  
Atmedica.
  
	
   
  	
   
  
	
  -
  	
  MediMedia.
  

64Lease Agreement

     

    Exhibit
      4.6

    

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      
        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

        

         

        

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

         

        

         

         

        
          
             

          

          
             

            
              

            

          

          
             

          

        

        

        End
          of
          Exhibit

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]